Association counts use unique genes with 01-High Priority evidence and unique cells in the authored Specific tier (not the IC-score significance threshold). Reverse counts list meta traits and individual traits separately; these are overlapping levels of evidence, not independent totals. Counts cover the full available catalogue, not the displayed rows or sampled UMAP. Unavailable profiles are excluded from reverse counts; a dash means unavailable or an ambiguous identity, not zero. The browser initially shows 50 rows; choose Rows to change this. Complete rows remain in the HTML, and ordinary page links expose any continuation pages for AI readers and crawlers.
FIB.perivascular_interface: Meta traits
How association tiers are defined — cell–trait and gene–trait
SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.
Cell–trait tiers
- Cell–trait links
- Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
- Required for Specific or Relevant
- The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
- Specific (Tier 1)
- Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
- Relevant (Tier 2)
- Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
- Interpretation and report values
- CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
- Meta traits and individual traits
- Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.
Gene–trait priorities (variant–tCRE–gene evidence)
- Variant–tCRE–gene links
- Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
- Required genetic support
- The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
- Required cellular support
- The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
- High priority
- Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
- Medium priority
- Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
- Same-record evidence and aggregation
- Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
- Limits of interpretation
- A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.
Subtype · 829 full-atlas cells · all tissues.
Marker genes and cell annotation · Open this population in Cell Browser →
ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.
Rows 1–1,000 of 5,288; ranked by score descending. Equal values use name/identifier order.
| Browsers | # | Trait | Trait code | Mean IC score | Category | Main cell contexts | Genes (High Priority) | L1 cells (Specific) | L1S cells (Specific) | L2 cells (Specific) |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Nerve entrapment syndrome | NEURO000028 | 25.43 | Neurologic | Stromal / connective | 19 | 4 | 7 | 12 | |
| 2 | Height | BMORP000009 | 18.57 | Body morphology | Stromal / connective | 3,280 | 3 | 4 | 6 | |
| 3 | Hand grip strength | MSKEL000030 | 17.61 | Musculoskeletal | Stromal / connective | 131 | 5 | 7 | 13 | |
| 4 | Lean mass | BCOMP000009 | 17.41 | Body composition | Stromal / connective | 897 | 4 | 7 | 8 | |
| 5 | Physical function | MISCL000041 | 15.94 | Miscellaneous | Stromal / connective | 502 | 3 | 4 | 9 | |
| 6 | Body size, adult | BMORP000003 | 14.48 | Body morphology | Stromal / connective | 300 | 3 | 6 | 8 | |
| 7 | Arm impedance | BCOMP000013 | 14.07 | Body composition | Stromal / connective | 665 | 4 | 6 | 12 | |
| 8 | Waist circumference, adjusted for BMI | BMORP000006 | 13.73 | Body morphology | Stromal / connective | 314 | 3 | 3 | 9 | |
| 9 | Trunk mass | BCOMP000019 | 13.37 | Body composition | Stromal / connective | 381 | 4 | 10 | 14 | |
| 10 | Body water mass | BCOMP000006 | 13.04 | Body composition | Stromal / connective | 324 | 5 | 10 | 21 | |
| 11 | Heel quantitative ultrasound | MSKEL000005 | 12.32 | Musculoskeletal | Stromal / connective | 361 | 3 | 8 | 12 | |
| 12 | Ankle spacing width | MSKEL000056 | 12.09 | Musculoskeletal | Stromal / connective | 338 | 2 | 5 | 6 | |
| 13 | RET levels | PROLV001724 | 11.65 | Protein levels | Stromal / connective | 18 | 5 | 10 | 21 | |
| 14 | Hip circumference, adjusted for BMI | BMORP000005 | 11.16 | Body morphology | Stromal / connective | 326 | 5 | 6 | 10 | |
| 15 | Consultant specialty, ophthalmology | MISCL000018 | 10.92 | Miscellaneous | Vascular | 0 | 4 | 12 | 22 | |
| 16 | Whole body impedance | BCOMP000007 | 10.92 | Body composition | Stromal / connective | 553 | 5 | 7 | 15 | |
| 17 | Arm mass | BCOMP000014 | 10.71 | Body composition | Stromal / connective | 302 | 4 | 9 | 13 | |
| 18 | Fat-free mass | BCOMP000008 | 10.70 | Body composition | Stromal / connective | 273 | 6 | 9 | 12 | |
| 19 | Hip index | BMORP000012 | 10.38 | Body morphology | Adipose | 121 | 3 | 4 | 14 | |
| 20 | Bone mineral density | MSKEL000004 | 10.23 | Musculoskeletal | Stromal / connective | 350 | 3 | 8 | 10 | |
| 21 | Leg impedance | BCOMP000016 | 9.96 | Body composition | Stromal / connective | 562 | 4 | 7 | 19 | |
| 22 | Basal metabolic rate | METBL000007 | 9.93 | Metabolic | Neural / glial | 298 | 6 | 10 | 20 | |
| 23 | Kidney volume | NEPHR000022 | 9.32 | Nephrourologic | Stromal / connective | 1 | 3 | 8 | 25 | |
| 24 | Spinal deformity | MSKEL000077 | 9.31 | Musculoskeletal | Stromal / connective | 0 | 2 | 5 | 13 | |
| 25 | Body proportion | BMORP000019 | 9.27 | Body morphology | Stromal / connective | 71 | 3 | 8 | 8 | |
| 26 | Forced vital capacity, FVC | RESPI000020 | 8.77 | Respiratory | Stromal / connective | 487 | 4 | 6 | 8 | |
| 27 | TNXB levels | PROLV002085 | 8.74 | Protein levels | Stromal / connective | 56 | 4 | 7 | 22 | |
| 28 | HSPG2/IGFBP6 ratio | PRORT001307 | 8.69 | Protein ratios | Adipose | 15 | 3 | 9 | 18 | |
| 29 | Blood pressure, BP, pulse | VASCU000010 | 8.63 | Vascular | Stromal / connective | 1,008 | 5 | 7 | 16 | |
| 30 | Corneal properties | OPHTH000010 | 8.43 | Ophthalmic | Stromal / connective | 279 | 3 | 5 | 10 | |
| 31 | Peak expiratory flow | RESPI000023 | 8.35 | Respiratory | Stromal / connective | 305 | 2 | 5 | 8 | |
| 32 | Leg mass | BCOMP000017 | 8.26 | Body composition | Neural / glial | 384 | 5 | 10 | 15 | |
| 33 | LAMB1 levels | PROLV001179 | 8.19 | Protein levels | Stromal / connective | 44 | 2 | 9 | 22 | |
| 34 | Atrial volume | CARDI000009 | 8.18 | Cardiac | Stromal / connective | 0 | 3 | 9 | 19 | |
| 35 | Forced expiratory volume, FEV | RESPI000019 | 8.10 | Respiratory | Stromal / connective | 370 | 1 | 5 | 13 | |
| 36 | Pelvic morphology | BMORP000021 | 8.06 | Body morphology | Stromal / connective | 54 | 3 | 5 | 6 | |
| 37 | A body shape index, ABSI | BMORP000001 | 8.05 | Body morphology | Stromal / connective | 203 | 3 | 6 | 12 | |
| 38 | VCAN levels | PROLV002156 | 7.95 | Protein levels | Adipose | 116 | 3 | 8 | 21 | |
| 39 | ASPN levels | PROLV000153 | 7.70 | Protein levels | Stromal / connective | 10 | 4 | 12 | 35 | |
| 40 | SCARA5 levels | PROLV001780 | 7.66 | Protein levels | Stromal / connective | 8 | 2 | 4 | 9 | |
| 41 | EGFR/FAP ratio | PRORT001000 | 7.50 | Protein ratios | Adipose | 52 | 4 | 8 | 17 | |
| 42 | COL24A1 levels | PROLV000486 | 7.40 | Protein levels | Stromal / connective | 2 | 5 | 10 | 25 | |
| 43 | COL6A3/CST3 ratio | PRORT000696 | 7.35 | Protein ratios | Adipose | 33 | 3 | 8 | 18 | |
| 44 | Corneal keratometry | OPHTH000006 | 7.28 | Ophthalmic | Stromal / connective | 298 | 3 | 5 | 8 | |
| 45 | HMCN2 levels | PROLV000977 | 7.23 | Protein levels | Stromal / connective | 14 | 5 | 10 | 18 | |
| 46 | Lens replacement | OPHTH000025 | 7.19 | Ophthalmic | Vascular | 12 | 2 | 13 | 17 | |
| 47 | BCAN/MOG ratio | PRORT000217 | 6.98 | Protein ratios | Myeloid | 5 | 1 | 6 | 12 | |
| 48 | Waist-hip ratio | BMORP000014 | 6.91 | Body morphology | Adipose | 523 | 3 | 5 | 10 | |
| 49 | DLK1/FAP ratio | PRORT000911 | 6.90 | Protein ratios | Adipose | 26 | 4 | 8 | 25 | |
| 50 | Intraocular pressure | OPHTH000011 | 6.73 | Ophthalmic | Stromal / connective | 184 | 4 | 6 | 10 | |
| 51 | Diverticular disease | GASTR000011 | 6.72 | Gastrointestinal | Stromal / connective | 95 | 3 | 6 | 17 | |
| 52 | Precerebral arterial stenosis and occlusion | VASCU000016 | 6.62 | Vascular | Stromal / connective | 91 | 2 | 11 | 22 | |
| 53 | NPL levels | PROLV001423 | 6.58 | Protein levels | Myeloid | 36 | 4 | 8 | 19 | |
| 54 | BCAN/DPP6 ratio | PRORT000215 | 6.45 | Protein ratios | Stromal / connective | 0 | 5 | 11 | 20 | |
| 55 | CBLN4 levels | PROLV000272 | 6.32 | Protein levels | Adipose | 11 | 2 | 8 | 9 | |
| 56 | Medication, antiglaucoma | OPHTH000014 | 6.23 | Ophthalmic | Stromal / connective | 69 | 2 | 5 | 12 | |
| 57 | COL6A3/OGN ratio | PRORT000699 | 6.18 | Protein ratios | Adipose | 33 | 5 | 8 | 16 | |
| 58 | VSNL1 levels | PROLV002173 | 6.14 | Protein levels | Myeloid | 44 | 2 | 9 | 20 | |
| 59 | MAMDC2 levels | PROLV001258 | 6.08 | Protein levels | Stromal / connective | 36 | 5 | 8 | 14 | |
| 60 | PSG1 levels | PROLV001656 | 6.00 | Protein levels | Myeloid | 41 | 4 | 13 | 21 | |
| 61 | Heart failure, with coronary heart disease | CARDI000005 | 5.91 | Cardiac | Stromal / connective | 54 | 3 | 9 | 17 | |
| 62 | ANGPTL7 levels | PROLV000099 | 5.88 | Protein levels | Stromal / connective | 32 | 2 | 9 | 13 | |
| 63 | Thigh muscle volume | BMORP000020 | 5.88 | Body morphology | Muscle / cardiac | 16 | 4 | 8 | 17 | |
| 64 | Acquired foot deformities | MSKEL000052 | 5.85 | Musculoskeletal | Stromal / connective | 38 | 2 | 5 | 12 | |
| 65 | COL6A3/COLEC12 ratio | PRORT000695 | 5.85 | Protein ratios | Adipose | 53 | 4 | 9 | 18 | |
| 66 | TNC levels | PROLV002052 | 5.78 | Protein levels | Adipose | 35 | 2 | 6 | 11 | |
| 67 | Aortic aneurysm | VASCU000002 | 5.77 | Vascular | Vascular | 163 | 5 | 11 | 20 | |
| 68 | Sex-differentiated cardiometabolic traits | MISCL000002 | 5.74 | Miscellaneous | Hepatocyte | 733 | 1 | 9 | 15 | |
| 69 | Aortic valve disease | CARDI000053 | 5.65 | Cardiac | Vascular | 83 | 5 | 9 | 17 | |
| 70 | Trunk fat percentage | BCOMP000018 | 5.49 | Body composition | Neural / glial | 276 | 3 | 10 | 17 | |
| 71 | Physical decline | AGING000005 | 5.45 | Aging | Muscle / cardiac | 0 | 4 | 15 | 14 | |
| 72 | Fasciectomy | MSKEL000045 | 5.41 | Musculoskeletal | Stromal / connective | 11 | 3 | 8 | 14 | |
| 73 | CST3/IGFBP6 ratio | PRORT000783 | 5.39 | Protein ratios | Stromal / connective | 7 | 3 | 15 | 19 | |
| 74 | EFEMP1/TGFBR3 ratio | PRORT000988 | 5.37 | Protein ratios | Stromal / connective | 5 | 3 | 7 | 15 | |
| 75 | Rotator cuff injury | MSKEL000067 | 5.33 | Musculoskeletal | Stromal / connective | 0 | 3 | 7 | 17 | |
| 76 | PSPN levels | PROLV001661 | 5.30 | Protein levels | Stromal / connective | 26 | 4 | 9 | 11 | |
| 77 | BCL2 levels | PROLV000185 | 5.28 | Protein levels | Lymphocyte | 0 | 5 | 18 | 27 | |
| 78 | COMP levels | PROLV000496 | 5.27 | Protein levels | Myeloid | 133 | 3 | 11 | 17 | |
| 79 | ROBO2 levels | PROLV001750 | 5.22 | Protein levels | Adipose | 69 | 5 | 10 | 24 | |
| 80 | ACVRL1/TNFRSF19 ratio | PRORT000017 | 5.10 | Protein ratios | Vascular | 20 | 2 | 7 | 15 | |
| 81 | Synovium, tendon and bursa disorder | MSKEL000057 | 5.10 | Musculoskeletal | Stromal / connective | 1 | 2 | 4 | 7 | |
| 82 | FAP levels | PROLV000769 | 5.01 | Protein levels | Adipose | 78 | 7 | 12 | 27 | |
| 83 | Operation, hernia | GASTR000040 | 4.94 | Gastrointestinal | Adipose | 21 | 2 | 5 | 9 | |
| 84 | PRELP levels | PROLV001627 | 4.94 | Protein levels | Stromal / connective | 71 | 4 | 9 | 11 | |
| 85 | CCN3/FAP ratio | PRORT000373 | 4.89 | Protein ratios | Hepatocyte | 27 | 4 | 11 | 24 | |
| 86 | Glaucoma | OPHTH000009 | 4.83 | Ophthalmic | Stromal / connective | 407 | 3 | 7 | 9 | |
| 87 | CILP levels | PROLV000436 | 4.83 | Protein levels | Myeloid | 47 | 5 | 12 | 21 | |
| 88 | Hernia | GASTR000008 | 4.82 | Gastrointestinal | Stromal / connective | 183 | 2 | 4 | 8 | |
| 89 | BOC levels | PROLV000207 | 4.77 | Protein levels | Stromal / connective | 7 | 5 | 15 | 42 | |
| 90 | Fibroblastic disorder | MSKEL000064 | 4.74 | Musculoskeletal | Stromal / connective | 49 | 3 | 6 | 10 | |
| 91 | Aneurysm | VASCU000001 | 4.74 | Vascular | Hepatocyte | 141 | 4 | 8 | 22 | |
| 92 | Trigger finger | MSKEL000072 | 4.67 | Musculoskeletal | Stromal / connective | 7 | 2 | 4 | 8 | |
| 93 | Retinal and choroidal disorder | OPHTH000038 | 4.63 | Ophthalmic | Stromal / connective | 74 | 4 | 9 | 18 | |
| 94 | CNTN1 levels | PROLV000475 | 4.60 | Protein levels | Stromal / connective | 121 | 4 | 10 | 25 | |
| 95 | Cardiac procedure, angioplasty | VASCU000057 | 4.57 | Vascular | Vascular | 102 | 4 | 10 | 20 | |
| 96 | Haemorrhoidal disease | VASCU000062 | 4.56 | Vascular | Vascular | 67 | 4 | 9 | 16 | |
| 97 | Aortic diameter | VASCU000052 | 4.52 | Vascular | Muscle / cardiac | 215 | 5 | 7 | 19 | |
| 98 | Musculoskeletal soft tissue disorder | MSKEL000029 | 4.50 | Musculoskeletal | Stromal / connective | 30 | 4 | 7 | 17 | |
| 99 | Coronary revascularization | VASCU000059 | 4.44 | Vascular | Vascular | 384 | 4 | 9 | 25 | |
| 100 | COL6A3/TAFA5 ratio | PRORT000702 | 4.42 | Protein ratios | Hepatocyte | 31 | 5 | 7 | 24 | |
| 101 | APP/CD40LG ratio | PRORT000122 | 4.41 | Protein ratios | Hematopoietic progenitor | 0 | 4 | 13 | 32 | |
| 102 | SFRP4 levels | PROLV001846 | 4.41 | Protein levels | Stromal / connective | 10 | 3 | 7 | 9 | |
| 103 | COL4A1 levels | PROLV000490 | 4.40 | Protein levels | Hepatocyte | 117 | 3 | 10 | 16 | |
| 104 | COL6A3/HSPG2 ratio | PRORT000697 | 4.37 | Protein ratios | Stromal / connective | 49 | 3 | 7 | 15 | |
| 105 | DPP10 levels | PROLV000645 | 4.31 | Protein levels | Vascular | 10 | 2 | 9 | 19 | |
| 106 | C7 levels | PROLV000236 | 4.30 | Protein levels | Adipose | 12 | 2 | 11 | 27 | |
| 107 | Gestational age at birth | REPRO000040 | 4.30 | Reproductive | Neural / glial | 0 | 1 | 7 | 10 | |
| 108 | AXL/MSR1 ratio | PRORT000182 | 4.28 | Protein ratios | Myeloid | 28 | 4 | 16 | 18 | |
| 109 | Leukoencephalopathy | NEURO000004 | 4.25 | Neurologic | Stromal / connective | 2 | 2 | 10 | 7 | |
| 110 | ADAMTSL2 levels | PROLV000036 | 4.24 | Protein levels | Hepatocyte | 72 | 3 | 14 | 23 | |
| 111 | Tympanic membrane perforation | AUDIO000019 | 4.24 | Auditory | Stromal / connective | 5 | 3 | 6 | 8 | |
| 112 | DBH levels | PROLV000596 | 4.18 | Protein levels | Myeloid | 48 | 2 | 8 | 16 | |
| 113 | Knee morphology | MSKEL000024 | 4.18 | Musculoskeletal | Stromal / connective | 0 | 4 | 7 | 17 | |
| 114 | COLEC12/OGN ratio | PRORT000705 | 4.17 | Protein ratios | Stromal / connective | 12 | 3 | 11 | 19 | |
| 115 | ANGPTL3/TFPI ratio | PRORT000099 | 4.13 | Protein ratios | Hepatocyte | 73 | 2 | 11 | 18 | |
| 116 | ZNRF4 levels | PROLV002214 | 4.11 | Protein levels | Adipose | 7 | 5 | 11 | 14 | |
| 117 | TNC/VCAM1 ratio | PRORT001843 | 4.11 | Protein ratios | Adipose | 38 | 3 | 10 | 13 | |
| 118 | Retinal detachments and defects | OPHTH000039 | 4.10 | Ophthalmic | Stromal / connective | 2 | 3 | 7 | 22 | |
| 119 | EPS8L2 levels | PROLV000723 | 4.09 | Protein levels | Stromal / connective | 20 | 0 | 10 | 20 | |
| 120 | CDON levels | PROLV000385 | 4.06 | Protein levels | Granulosa cell | 4 | 5 | 10 | 14 | |
| 121 | Eye disorder | OPHTH000008 | 4.06 | Ophthalmic | Neural / glial | 4 | 1 | 1 | 7 | |
| 122 | Cardiac angiography | CARDI000047 | 4.02 | Cardiac | Stromal / connective | 14 | 3 | 8 | 17 | |
| 123 | ANGPTL2 levels | PROLV000096 | 4.00 | Protein levels | Stromal / connective | 48 | 3 | 17 | 12 | |
| 124 | COMP/DPP4 ratio | PRORT000709 | 3.98 | Protein ratios | Myeloid | 32 | 4 | 13 | 18 | |
| 125 | CLMP/TNFRSF19 ratio | PRORT000671 | 3.93 | Protein ratios | Stromal / connective | 0 | 2 | 3 | 9 | |
| 126 | PLXDC2 levels | PROLV001584 | 3.93 | Protein levels | Granulosa cell | 18 | 4 | 16 | 23 | |
| 127 | THBS2 levels | PROLV002026 | 3.90 | Protein levels | Lymphocyte | 30 | 2 | 11 | 39 | |
| 128 | LRRN1 levels | PROLV001236 | 3.87 | Protein levels | Muscle / cardiac | 81 | 3 | 8 | 25 | |
| 129 | Diffuse idiopathic skeletal hyperostosis | MSKEL000074 | 3.87 | Musculoskeletal | Hematopoietic progenitor | 1 | 2 | 6 | 16 | |
| 130 | Carpal tunnel surgery | MSKEL000044 | 3.86 | Musculoskeletal | Stromal / connective | 5 | 4 | 6 | 11 | |
| 131 | CHCHD10 levels | PROLV000424 | 3.86 | Protein levels | Muscle / cardiac | 0 | 4 | 8 | 21 | |
| 132 | SLC9A3R2 levels | PROLV001886 | 3.86 | Protein levels | Vascular | 16 | 2 | 7 | 14 | |
| 133 | BPIFB1/GLRX ratio | PRORT000245 | 3.85 | Protein ratios | Adipose | 0 | 4 | 9 | 18 | |
| 134 | CLMP/PIK3IP1 ratio | PRORT000669 | 3.85 | Protein ratios | Adipose | 1 | 3 | 6 | 10 | |
| 135 | Digital deformity | MSKEL000053 | 3.84 | Musculoskeletal | Stromal / connective | 0 | 5 | 8 | 33 | |
| 136 | Snoring | RESPI000036 | 3.81 | Respiratory | Neural / glial | 12 | 3 | 11 | 32 | |
| 137 | MATN2 levels | PROLV001277 | 3.80 | Protein levels | Stromal / connective | 78 | 3 | 6 | 14 | |
| 138 | FEV1/FVC ratio | RESPI000021 | 3.80 | Respiratory | Stromal / connective | 549 | 3 | 4 | 17 | |
| 139 | AFM levels | PROLV000052 | 3.80 | Protein levels | Hepatocyte | 24 | 1 | 7 | 20 | |
| 140 | S100A12 levels | PROLV001767 | 3.74 | Protein levels | Lymphocyte | 6 | 3 | 14 | 39 | |
| 141 | AOC3/ITGB1 ratio | PRORT000113 | 3.73 | Protein ratios | Stromal / connective | 16 | 3 | 14 | 10 | |
| 142 | ADAMTS8 levels | PROLV000035 | 3.73 | Protein levels | Muscle / cardiac | 48 | 3 | 5 | 11 | |
| 143 | ITGA2 levels | PROLV001105 | 3.71 | Protein levels | Vascular | 76 | 3 | 13 | 27 | |
| 144 | C21orf58 levels | PROLV000231 | 3.67 | Protein levels | Hepatocyte | 0 | 4 | 10 | 17 | |
| 145 | MSMB levels | PROLV001341 | 3.67 | Protein levels | Stromal / connective | 32 | 3 | 9 | 14 | |
| 146 | Spondylolisthesis or spondylolysis | MSKEL000079 | 3.65 | Musculoskeletal | Stromal / connective | 0 | 3 | 5 | 13 | |
| 147 | EFEMP1/FSTL3 ratio | PRORT000986 | 3.65 | Protein ratios | Stromal / connective | 14 | 4 | 6 | 20 | |
| 148 | TGFBR3 levels | PROLV002023 | 3.64 | Protein levels | Adipose | 33 | 3 | 6 | 14 | |
| 149 | SCARA5/TNC ratio | PRORT001760 | 3.64 | Protein ratios | Granulosa cell | 39 | 2 | 9 | 13 | |
| 150 | ENG levels | PROLV000704 | 3.63 | Protein levels | Adipose | 10 | 4 | 12 | 30 | |
| 151 | Pregnancy complication, obstructed labour | REPRO000031 | 3.62 | Reproductive | Stromal / connective | 0 | 3 | 6 | 11 | |
| 152 | DLL4 levels | PROLV000627 | 3.62 | Protein levels | Epithelial | 2 | 1 | 10 | 16 | |
| 153 | FAP/THBS4 ratio | PRORT001117 | 3.61 | Protein ratios | Hepatocyte | 21 | 4 | 12 | 33 | |
| 154 | Fall risk | MSKEL000043 | 3.61 | Musculoskeletal | Stromal / connective | 1 | 0 | 5 | 10 | |
| 155 | Medication, post-myocardial infarction | CARDI000045 | 3.59 | Cardiac | Vascular | 76 | 4 | 9 | 11 | |
| 156 | Visual impairment | OPHTH000046 | 3.59 | Ophthalmic | Stromal / connective | 28 | 0 | 2 | 7 | |
| 157 | Spinal stenosis | MSKEL000078 | 3.58 | Musculoskeletal | Stromal / connective | 43 | 4 | 9 | 11 | |
| 158 | Body size, birth | BMORP000017 | 3.55 | Body morphology | Vascular | 12 | 2 | 6 | 9 | |
| 159 | FNDC1 levels | PROLV000820 | 3.55 | Protein levels | Hepatocyte | 14 | 3 | 13 | 22 | |
| 160 | ADGRB3 levels | PROLV000040 | 3.54 | Protein levels | Stromal / connective | 34 | 5 | 8 | 25 | |
| 161 | TNFRSF4/TNFRSF9 ratio | PRORT001854 | 3.53 | Protein ratios | Stromal / connective | 5 | 2 | 8 | 18 | |
| 162 | Weight, birth | BMORP000018 | 3.52 | Body morphology | Vascular | 117 | 2 | 6 | 16 | |
| 163 | VNN2 levels | PROLV002165 | 3.49 | Protein levels | Myeloid | 72 | 2 | 11 | 14 | |
| 164 | Medication, coronary artery disease | VASCU000037 | 3.48 | Vascular | Vascular | 121 | 5 | 8 | 17 | |
| 165 | Fatty liver disease, nonalcoholic overweight | HPBIL000030 | 3.47 | Hepatopancreatobiliary | Neural / glial | 1 | 0 | 3 | 9 | |
| 166 | IGF1 levels | PROLV001025 | 3.46 | Protein levels | Hepatocyte | 1,341 | 1 | 7 | 13 | |
| 167 | DLK1 levels | PROLV000625 | 3.46 | Protein levels | Muscle / cardiac | 29 | 4 | 9 | 25 | |
| 168 | Medication, antithrombotic | VASCU000033 | 3.45 | Vascular | Vascular | 37 | 4 | 10 | 12 | |
| 169 | PRTG levels | PROLV001650 | 3.45 | Protein levels | Hepatocyte | 34 | 4 | 11 | 17 | |
| 170 | PKD1 levels | PROLV001564 | 3.45 | Protein levels | Vascular | 84 | 4 | 11 | 19 | |
| 171 | Hearing loss, conductive | AUDIO000007 | 3.42 | Auditory | Stromal / connective | 3 | 1 | 7 | 10 | |
| 172 | Coronary artery disease, CAD | VASCU000020 | 3.40 | Vascular | Vascular | 661 | 3 | 10 | 23 | |
| 173 | Lens disorder | OPHTH000013 | 3.39 | Ophthalmic | Stromal / connective | 3 | 5 | 8 | 10 | |
| 174 | Intracerebral haemorrhage | VASCU000014 | 3.38 | Vascular | Stromal / connective | 0 | 6 | 14 | 20 | |
| 175 | CREG1/NAAA ratio | PRORT000752 | 3.33 | Protein ratios | Granulosa cell | 9 | 3 | 11 | 23 | |
| 176 | Aplastic anaemia | HEMAT000004 | 3.32 | Hematologic | Muscle / cardiac | 0 | 2 | 5 | 18 | |
| 177 | CD34 levels | PROLV000336 | 3.31 | Protein levels | Stromal / connective | 67 | 3 | 10 | 21 | |
| 178 | ECG-predicted BMI discrepancy | BMORP000008 | 3.31 | Body morphology | Muscle / cardiac | 0 | 2 | 5 | 20 | |
| 179 | Medication, macular degeneration | OPHTH000015 | 3.30 | Ophthalmic | Hepatocyte | 41 | 3 | 11 | 20 | |
| 180 | Cystatin C | NEPHR000019 | 3.29 | Nephrourologic | Myeloid | 898 | 1 | 7 | 9 | |
| 181 | MIA levels | PROLV001311 | 3.28 | Protein levels | Neural / glial | 91 | 4 | 7 | 14 | |
| 182 | SIGLEC7 levels | PROLV001863 | 3.25 | Protein levels | Myeloid | 20 | 1 | 13 | 11 | |
| 183 | White matter lesion volume | NIMAG000027 | 3.24 | Neuroimaging | Stromal / connective | 30 | 4 | 10 | 14 | |
| 184 | PCDH7 levels | PROLV001507 | 3.23 | Protein levels | Neural / glial | 6 | 2 | 9 | 16 | |
| 185 | TGFBR2/TNFRSF19 ratio | PRORT001834 | 3.22 | Protein ratios | Neural / glial | 12 | 3 | 7 | 13 | |
| 186 | FUT8/TNFSF14 ratio | PRORT001192 | 3.22 | Protein ratios | Adipose | 13 | 4 | 22 | 56 | |
| 187 | ADGRE5/GAS6 ratio | PRORT000030 | 3.21 | Protein ratios | Myeloid | 116 | 4 | 10 | 23 | |
| 188 | MOG/RTBDN ratio | PRORT001552 | 3.21 | Protein ratios | Stromal / connective | 4 | 2 | 8 | 21 | |
| 189 | Prolapse, pelvic organ | REPRO000025 | 3.20 | Reproductive | Stromal / connective | 35 | 3 | 6 | 13 | |
| 190 | GFRA1 levels | PROLV000876 | 3.19 | Protein levels | Myeloid | 22 | 2 | 8 | 15 | |
| 191 | Coronary artery calcification | VASCU000055 | 3.18 | Vascular | Vascular | 56 | 4 | 6 | 11 | |
| 192 | GABARAPL1 levels | PROLV000844 | 3.18 | Protein levels | Hepatocyte | — | 2 | 8 | 14 | |
| 193 | NPY levels | PROLV001429 | 3.17 | Protein levels | Hepatocyte | 131 | 2 | 6 | 21 | |
| 194 | CCDC80/CCL27 ratio | PRORT000332 | 3.16 | Protein ratios | Myeloid | 40 | 3 | 6 | 28 | |
| 195 | CTSZ/NAAA ratio | PRORT000805 | 3.15 | Protein ratios | Stromal / connective | 45 | 2 | 10 | 14 | |
| 196 | Vitamin E | METAB000079 | 3.14 | Metabolites | Hepatocyte | 2 | 1 | 5 | 12 | |
| 197 | Retinal vascular disorder | OPHTH000044 | 3.10 | Ophthalmic | Vascular | 0 | 1 | 6 | 13 | |
| 198 | Bone infection | IMMUN000053 | 3.10 | Immunologic | Myeloid | 0 | 3 | 10 | 24 | |
| 199 | SIL1 levels | PROLV001866 | 3.09 | Protein levels | Stromal / connective | 1 | 4 | 14 | 21 | |
| 200 | Angina pectoris | CARDI000039 | 3.09 | Cardiac | Vascular | 317 | 5 | 9 | 18 | |
| 201 | PSME2/RBKS ratio | PRORT001713 | 3.05 | Protein ratios | Hepatocyte | 23 | 4 | 15 | 13 | |
| 202 | WIF1 levels | PROLV002193 | 3.05 | Protein levels | Vascular | 116 | 2 | 7 | 15 | |
| 203 | EFEMP1/IL18BP ratio | PRORT000987 | 3.05 | Protein ratios | Stromal / connective | 1 | 1 | 6 | 16 | |
| 204 | FCRL2/TNFRSF13B ratio | PRORT001132 | 3.05 | Protein ratios | B / plasma cell | 10 | 3 | 8 | 18 | |
| 205 | COMP/MYOC ratio | PRORT000712 | 3.00 | Protein ratios | Adipose | 3 | 4 | 14 | 23 | |
| 206 | CASP1 levels | PROLV000265 | 2.98 | Protein levels | Myeloid | 55 | 2 | 10 | 18 | |
| 207 | BMP4 levels | PROLV000203 | 2.98 | Protein levels | Granulosa cell | 46 | 2 | 8 | 26 | |
| 208 | Hip joint morphology | MSKEL000023 | 2.98 | Musculoskeletal | Stromal / connective | 56 | 2 | 4 | 7 | |
| 209 | PAMR1 levels | PROLV001493 | 2.97 | Protein levels | Myeloid | 137 | 3 | 13 | 23 | |
| 210 | Adhesive capsulitis | MSKEL000058 | 2.97 | Musculoskeletal | Stromal / connective | 26 | 1 | 5 | 13 | |
| 211 | CST3/TFF3 ratio | PRORT000788 | 2.97 | Protein ratios | Adipose | 7 | 1 | 9 | 12 | |
| 212 | ITGAV levels | PROLV001110 | 2.96 | Protein levels | Hepatocyte | 116 | 4 | 14 | 24 | |
| 213 | Paradoxical eczema | IMMUN000036 | 2.96 | Immunologic | Myeloid | 0 | 1 | 6 | 16 | |
| 214 | DLK1/PIK3IP1 ratio | PRORT000912 | 2.95 | Protein ratios | Stromal / connective | 1 | 4 | 10 | 35 | |
| 215 | Foot surgery | MSKEL000046 | 2.95 | Musculoskeletal | Hematopoietic progenitor | 2 | 2 | 6 | 12 | |
| 216 | PDGFC/TFPI ratio | PRORT001653 | 2.95 | Protein ratios | Hepatocyte | 52 | 2 | 12 | 21 | |
| 217 | ASGR1 levels | PROLV000151 | 2.93 | Protein levels | Hepatocyte | 61 | 5 | 15 | 29 | |
| 218 | Optic cup area | OPHTH000028 | 2.93 | Ophthalmic | Vascular | 5 | 3 | 9 | 14 | |
| 219 | AKR7L levels | PROLV000073 | 2.92 | Protein levels | Hepatocyte | 29 | 3 | 9 | 22 | |
| 220 | CTSD/PRCP ratio | PRORT000799 | 2.92 | Protein ratios | Hepatocyte | 16 | 2 | 10 | 21 | |
| 221 | COL6A3/NBL1 ratio | PRORT000698 | 2.92 | Protein ratios | Stromal / connective | 29 | 2 | 2 | 8 | |
| 222 | COL6A3 levels | PROLV000492 | 2.92 | Protein levels | Stromal / connective | 38 | 2 | 4 | 12 | |
| 223 | CCL11/CCL2 ratio | PRORT000335 | 2.91 | Protein ratios | Muscle / cardiac | 13 | 2 | 5 | 11 | |
| 224 | BIN2/PDLIM7 ratio | PRORT000233 | 2.91 | Protein ratios | Muscle / cardiac | 1 | 3 | 8 | 22 | |
| 225 | SSC5D levels | PROLV001948 | 2.90 | Protein levels | Vascular | 40 | 3 | 14 | 12 | |
| 226 | NEO1 levels | PROLV001392 | 2.89 | Protein levels | Muscle / cardiac | 0 | 3 | 11 | 19 | |
| 227 | SMOC1 levels | PROLV001899 | 2.89 | Protein levels | Hepatocyte | 129 | 1 | 6 | 15 | |
| 228 | HAMP levels | PROLV000950 | 2.89 | Protein levels | Vascular | 8 | 5 | 10 | 10 | |
| 229 | CLU levels | PROLV000467 | 2.89 | Protein levels | Granulosa cell | 75 | 5 | 15 | 24 | |
| 230 | GFRAL levels | PROLV000879 | 2.88 | Protein levels | Vascular | 26 | 2 | 9 | 20 | |
| 231 | ITGA11 levels | PROLV001104 | 2.87 | Protein levels | Hepatocyte | 66 | 3 | 11 | 20 | |
| 232 | Aortic elasticity | VASCU000049 | 2.87 | Vascular | Vascular | 20 | 3 | 5 | 12 | |
| 233 | APOF levels | PROLV000125 | 2.86 | Protein levels | Hepatocyte | 56 | 4 | 10 | 22 | |
| 234 | Osteoarthritis, OA | MSKEL000012 | 2.86 | Musculoskeletal | Stromal / connective | 85 | 1 | 2 | 6 | |
| 235 | ADGRD1 levels | PROLV000041 | 2.85 | Protein levels | Hepatocyte | 47 | 5 | 12 | 15 | |
| 236 | FGR levels | PROLV000804 | 2.84 | Protein levels | Adipose | 16 | 7 | 15 | 30 | |
| 237 | CTSO levels | PROLV000567 | 2.81 | Protein levels | Myeloid | 112 | 2 | 11 | 27 | |
| 238 | POSTN levels | PROLV001603 | 2.80 | Protein levels | Adipose | 40 | 1 | 5 | 14 | |
| 239 | FN1 levels | PROLV000819 | 2.80 | Protein levels | Myeloid | 76 | 5 | 15 | 27 | |
| 240 | Fasciitis | MSKEL000063 | 2.80 | Musculoskeletal | Stromal / connective | 16 | 1 | 3 | 8 | |
| 241 | COL6A3/SMOC2 ratio | PRORT000700 | 2.80 | Protein ratios | Adipose | 34 | 4 | 6 | 17 | |
| 242 | CD40LG/TNFSF14 ratio | PRORT000454 | 2.80 | Protein ratios | Hepatocyte | 11 | 5 | 17 | 43 | |
| 243 | COMP/ITGAV ratio | PRORT000711 | 2.77 | Protein ratios | Myeloid | 58 | 3 | 11 | 18 | |
| 244 | Cataract | OPHTH000012 | 2.77 | Ophthalmic | Vascular | 103 | 0 | 4 | 9 | |
| 245 | CERT/MAX ratio | PRORT000605 | 2.76 | Protein ratios | Stromal / connective | 0 | 4 | 12 | 23 | |
| 246 | Optic disc morphology | OPHTH000030 | 2.76 | Ophthalmic | Vascular | 8 | 1 | 10 | 15 | |
| 247 | Barrett's oesophagus | GASTR000046 | 2.76 | Gastrointestinal | Stromal / connective | 11 | 2 | 6 | 14 | |
| 248 | SF3B4 levels | PROLV001843 | 2.75 | Protein levels | Myeloid | 8 | 3 | 11 | 20 | |
| 249 | SNX9/STIP1 ratio | PRORT001801 | 2.74 | Protein ratios | Vascular | 0 | 6 | 15 | 31 | |
| 250 | DLK1/RGMB ratio | PRORT000913 | 2.73 | Protein ratios | Hepatocyte | 11 | 4 | 9 | 23 | |
| 251 | Hypoxaemia | RESPI000029 | 2.73 | Respiratory | Vascular | 15 | 2 | 13 | 27 | |
| 252 | CD38/RELT ratio | PRORT000440 | 2.73 | Protein ratios | Muscle / cardiac | 2 | 2 | 9 | 17 | |
| 253 | LTBR levels | PROLV001244 | 2.72 | Protein levels | Hepatocyte | 115 | 1 | 6 | 17 | |
| 254 | Female genital disorder | REPRO000006 | 2.72 | Reproductive | Stromal / connective | 14 | 4 | 9 | 13 | |
| 255 | NCAM2 levels | PROLV001378 | 2.72 | Protein levels | Myeloid | 33 | 3 | 7 | 17 | |
| 256 | CHRDL2 levels | PROLV000434 | 2.72 | Protein levels | Adipose | 0 | 1 | 6 | 14 | |
| 257 | CD302 levels | PROLV000334 | 2.71 | Protein levels | Myeloid | 157 | 1 | 13 | 19 | |
| 258 | Sulcal opening distance | NIMAG000012 | 2.71 | Neuroimaging | Vascular | 11 | 5 | 9 | 18 | |
| 259 | PLXDC1 levels | PROLV001583 | 2.70 | Protein levels | Adipose | 4 | 2 | 13 | 38 | |
| 260 | Liver volume | HPBIL000025 | 2.70 | Hepatopancreatobiliary | Myeloid | 26 | 4 | 13 | 12 | |
| 261 | Ocular refraction | OPHTH000033 | 2.70 | Ophthalmic | Stromal / connective | 39 | 6 | 10 | 25 | |
| 262 | CCL13/CCL2 ratio | PRORT000338 | 2.70 | Protein ratios | Myeloid | 8 | 3 | 7 | 10 | |
| 263 | INHBB levels | PROLV001087 | 2.69 | Protein levels | Hepatocyte | 38 | 6 | 10 | 14 | |
| 264 | Corneal disorder | OPHTH000003 | 2.69 | Ophthalmic | Stromal / connective | 11 | 1 | 1 | 14 | |
| 265 | Arthropathy | MSKEL000013 | 2.69 | Musculoskeletal | Stromal / connective | 24 | 4 | 6 | 20 | |
| 266 | PECAM1/SOD2 ratio | PRORT001662 | 2.67 | Protein ratios | Myeloid | 17 | 5 | 13 | 18 | |
| 267 | CA2/TGM2 ratio | PRORT000278 | 2.66 | Protein ratios | Epithelial | 17 | 3 | 7 | 15 | |
| 268 | EGFR levels | PROLV000687 | 2.66 | Protein levels | Adipose | 22 | 3 | 10 | 13 | |
| 269 | B3GNT7 levels | PROLV000170 | 2.65 | Protein levels | Muscle / cardiac | 72 | 2 | 13 | 24 | |
| 270 | Pulmonary nodule | RESPI000018 | 2.64 | Respiratory | Lymphocyte | 2 | 3 | 19 | 36 | |
| 271 | PRL levels | PROLV001635 | 2.64 | Protein levels | Lymphocyte | 17 | 2 | 9 | 27 | |
| 272 | ADM/CLMP ratio | PRORT000045 | 2.64 | Protein ratios | B / plasma cell | 16 | 2 | 6 | 8 | |
| 273 | Endometriosis | REPRO000005 | 2.63 | Reproductive | Stromal / connective | 49 | 1 | 4 | 8 | |
| 274 | Arterial dissection | VASCU000003 | 2.63 | Vascular | Stromal / connective | 16 | 0 | 2 | 15 | |
| 275 | Peripheral nerve disorder | NEURO000031 | 2.63 | Neurologic | Stromal / connective | 5 | 2 | 5 | 10 | |
| 276 | GC levels | PROLV000864 | 2.61 | Protein levels | Myeloid | 15 | 2 | 7 | 19 | |
| 277 | Acquired absence of organs | MISCL000027 | 2.61 | Miscellaneous | Neural / glial | 1 | 4 | 12 | 15 | |
| 278 | Benign neoplasm, Adipose | MALIG000001 | 2.61 | Malignancy | Adipose | 1 | 2 | 6 | 14 | |
| 279 | DKKL1 levels | PROLV000623 | 2.59 | Protein levels | Hepatocyte | 77 | 4 | 10 | 25 | |
| 280 | VIT levels | PROLV002162 | 2.59 | Protein levels | Myeloid | 11 | 6 | 14 | 27 | |
| 281 | Cancer, Endometrium | MALIG000014 | 2.57 | Malignancy | Lymphocyte | 8 | 2 | 14 | 50 | |
| 282 | ISM1 levels | PROLV001102 | 2.56 | Protein levels | Hepatocyte | 88 | 3 | 14 | 29 | |
| 283 | HSD17B14 levels | PROLV000994 | 2.54 | Protein levels | Myeloid | 22 | 4 | 12 | 21 | |
| 284 | Male-pattern baldness | DERMA000032 | 2.54 | Dermatologic | Stromal / connective | 74 | 0 | 4 | 6 | |
| 285 | BCAN/NPTXR ratio | PRORT000219 | 2.51 | Protein ratios | Stromal / connective | 9 | 1 | 6 | 7 | |
| 286 | Bone fragility disorder | MSKEL000007 | 2.50 | Musculoskeletal | Adipose | 23 | 5 | 15 | 25 | |
| 287 | Coronary artery plaque burden | VASCU000056 | 2.50 | Vascular | Vascular | 37 | 3 | 5 | 9 | |
| 288 | CPXM2 levels | PROLV000512 | 2.49 | Protein levels | Muscle / cardiac | 0 | 2 | 4 | 14 | |
| 289 | GPA33 levels | PROLV000918 | 2.48 | Protein levels | Vascular | 66 | 2 | 10 | 11 | |
| 290 | AKR1B1 levels | PROLV000072 | 2.48 | Protein levels | Stromal / connective | 11 | 7 | 10 | 27 | |
| 291 | Consultant specialty, general surgery | MISCL000017 | 2.48 | Miscellaneous | Neural / glial | 3 | 2 | 4 | 10 | |
| 292 | FKBPL levels | PROLV000812 | 2.47 | Protein levels | Vascular | 10 | 1 | 6 | 12 | |
| 293 | Intracranial volume | NIMAG000025 | 2.46 | Neuroimaging | Muscle / cardiac | 0 | 3 | 8 | 18 | |
| 294 | BIRC2/CD40LG ratio | PRORT000235 | 2.46 | Protein ratios | Hepatocyte | 0 | 3 | 10 | 29 | |
| 295 | ALKBH3 levels | PROLV000080 | 2.45 | Protein levels | Myeloid | 0 | 4 | 14 | 18 | |
| 296 | ERBB2 levels | PROLV000724 | 2.45 | Protein levels | Hepatocyte | 97 | 1 | 8 | 17 | |
| 297 | DPP6/SEZ6L ratio | PRORT000947 | 2.45 | Protein ratios | Adipose | 8 | 3 | 10 | 14 | |
| 298 | OLR1 levels | PROLV001467 | 2.45 | Protein levels | Myeloid | 37 | 2 | 7 | 17 | |
| 299 | Osteoporosis | MSKEL000010 | 2.45 | Musculoskeletal | Stromal / connective | 5 | 3 | 5 | 21 | |
| 300 | TPM2 levels | PROLV002095 | 2.44 | Protein levels | Hepatocyte | 9 | 3 | 10 | 17 | |
| 301 | Toe deformity | MSKEL000055 | 2.44 | Musculoskeletal | Myeloid | 3 | 2 | 8 | 17 | |
| 302 | FAP/LRRN1 ratio | PRORT001116 | 2.44 | Protein ratios | Muscle / cardiac | 42 | 5 | 15 | 34 | |
| 303 | Brain neuroimaging feature | NIMAG000005 | 2.43 | Neuroimaging | Stromal / connective | 137 | 0 | 2 | 9 | |
| 304 | Operation, vascular | VASCU000058 | 2.43 | Vascular | Vascular | 116 | 4 | 7 | 10 | |
| 305 | Lung volume | RESPI000022 | 2.42 | Respiratory | Myeloid | 4 | 3 | 7 | 12 | |
| 306 | CALCA levels | PROLV000255 | 2.42 | Protein levels | Stromal / connective | 6 | 4 | 7 | 22 | |
| 307 | Skin sebum | DERMA000036 | 2.40 | Dermatologic | Stromal / connective | 0 | 2 | 6 | 12 | |
| 308 | IGFBP6/SMOC2 ratio | PRORT001338 | 2.40 | Protein ratios | Adipose | 2 | 3 | 8 | 13 | |
| 309 | AOC3 levels | PROLV000109 | 2.39 | Protein levels | Myeloid | 116 | 4 | 13 | 22 | |
| 310 | Carotid intima-media thickness | VASCU000053 | 2.39 | Vascular | Adipose | 15 | 2 | 5 | 12 | |
| 311 | CFH levels | PROLV000413 | 2.38 | Protein levels | Stromal / connective | 20 | 4 | 12 | 18 | |
| 312 | TMPRSS11D levels | PROLV002048 | 2.38 | Protein levels | Vascular | 3 | 2 | 5 | 12 | |
| 313 | PLA2G4A/PPP1R12A ratio | PRORT001673 | 2.37 | Protein ratios | Hepatocyte | 3 | 4 | 10 | 25 | |
| 314 | F9 levels | PROLV000750 | 2.36 | Protein levels | Myeloid | 24 | 6 | 12 | 31 | |
| 315 | Brain neuroimaging quality metric | NIMAG000006 | 2.36 | Neuroimaging | Muscle / cardiac | 29 | 1 | 2 | 6 | |
| 316 | Weight | BMORP000015 | 2.36 | Body morphology | Neural / glial | 1,549 | 3 | 8 | 22 | |
| 317 | SPON1 levels | PROLV001936 | 2.36 | Protein levels | Vascular | 33 | 0 | 2 | 7 | |
| 318 | Wisdom tooth surgery | DENTA000005 | 2.34 | Dental | B / plasma cell | 0 | 7 | 15 | 30 | |
| 319 | GFRA3 levels | PROLV000878 | 2.34 | Protein levels | Myeloid | 91 | 1 | 8 | 21 | |
| 320 | Hyperthyroidism, subclinical in pregnancy | ENDOC000011 | 2.31 | Endocrine | Adipose | 1 | 3 | 9 | 14 | |
| 321 | ALCAM/MSR1 ratio | PRORT000074 | 2.31 | Protein ratios | Myeloid | 30 | 2 | 10 | 13 | |
| 322 | CD59/SCARB2 ratio | PRORT000483 | 2.31 | Protein ratios | Myeloid | 16 | 4 | 10 | 20 | |
| 323 | IDS/SMPDL3A ratio | PRORT001330 | 2.31 | Protein ratios | Hepatocyte | 53 | 2 | 8 | 19 | |
| 324 | NHLRC3 levels | PROLV001403 | 2.28 | Protein levels | Stromal / connective | 23 | 5 | 9 | 27 | |
| 325 | DDR1 levels | PROLV000610 | 2.28 | Protein levels | Melanocyte | 92 | 3 | 14 | 23 | |
| 326 | ENO2/TXNDC5 ratio | PRORT001033 | 2.28 | Protein ratios | Hematopoietic progenitor | 6 | 4 | 7 | 18 | |
| 327 | EIF4G1/TBC1D23 ratio | PRORT001014 | 2.27 | Protein ratios | Adipose | 1 | 3 | 7 | 13 | |
| 328 | SLC39A5 levels | PROLV001881 | 2.26 | Protein levels | Hepatocyte | 133 | 4 | 11 | 29 | |
| 329 | MATN2/SCARA5 ratio | PRORT001494 | 2.26 | Protein ratios | Stromal / connective | 12 | 5 | 9 | 19 | |
| 330 | HEG1 levels | PROLV000961 | 2.26 | Protein levels | Vascular | 51 | 3 | 7 | 16 | |
| 331 | RBP2 levels | PROLV001711 | 2.26 | Protein levels | Neural / glial | 30 | 1 | 10 | 15 | |
| 332 | C3 levels | PROLV000232 | 2.25 | Protein levels | Myeloid | 55 | 2 | 6 | 14 | |
| 333 | Gut microbial abundance, Holdemania | GASTR000026 | 2.25 | Gastrointestinal | Hepatocyte | 0 | 3 | 13 | 24 | |
| 334 | MYOC levels | PROLV001363 | 2.25 | Protein levels | Vascular | 33 | 0 | 5 | 12 | |
| 335 | DKK3 levels | PROLV000621 | 2.24 | Protein levels | Myeloid | 56 | 3 | 10 | 17 | |
| 336 | NTPROBNP levels | PROLV001446 | 2.24 | Protein levels | Muscle / cardiac | 50 | 2 | 7 | 18 | |
| 337 | GFER/MAVS ratio | PRORT001205 | 2.23 | Protein ratios | Myeloid | 0 | 3 | 9 | 14 | |
| 338 | CCL13/CCL17 ratio | PRORT000337 | 2.22 | Protein ratios | Myeloid | 17 | 3 | 8 | 27 | |
| 339 | COL9A1 levels | PROLV000493 | 2.22 | Protein levels | Stromal / connective | 7 | 6 | 17 | 22 | |
| 340 | Varicose veins, VV | VASCU000061 | 2.21 | Vascular | Vascular | 132 | 1 | 4 | 11 | |
| 341 | TNFRSF14/TNFSF14 ratio | PRORT001851 | 2.20 | Protein ratios | Hepatocyte | 14 | 3 | 15 | 47 | |
| 342 | FAM3B levels | PROLV000766 | 2.20 | Protein levels | Gastrointestinal epithelium | 66 | 0 | 6 | 7 | |
| 343 | HJV levels | PROLV000971 | 2.20 | Protein levels | Hepatocyte | 12 | 4 | 12 | 35 | |
| 344 | AHCY/HSPA1A ratio | PRORT000055 | 2.19 | Protein ratios | Lymphocyte | 10 | 3 | 12 | 39 | |
| 345 | SCAMP3/VPS53 ratio | PRORT001757 | 2.19 | Protein ratios | Vascular | 0 | 2 | 9 | 19 | |
| 346 | HGF/TNFSF14 ratio | PRORT001286 | 2.19 | Protein ratios | Hepatocyte | 19 | 5 | 14 | 27 | |
| 347 | PILRA/TNFRSF1A ratio | PRORT001668 | 2.18 | Protein ratios | Adipose | 42 | 2 | 9 | 13 | |
| 348 | LGALS3 levels | PROLV001202 | 2.18 | Protein levels | Vascular | 28 | 1 | 2 | 8 | |
| 349 | Medication, renin-angiotensin system agent | VASCU000040 | 2.18 | Vascular | Vascular | 24 | 0 | 4 | 8 | |
| 350 | DCN levels | PROLV000601 | 2.17 | Protein levels | Myeloid | 65 | 3 | 10 | 14 | |
| 351 | CR2/TNFRSF13B ratio | PRORT000738 | 2.17 | Protein ratios | B / plasma cell | 32 | 3 | 9 | 15 | |
| 352 | CREG1/SMPDL3A ratio | PRORT000753 | 2.17 | Protein ratios | Hepatocyte | 10 | 2 | 10 | 28 | |
| 353 | MYOC/NOTCH3 ratio | PRORT001566 | 2.17 | Protein ratios | Hepatocyte | 9 | 1 | 8 | 24 | |
| 354 | ERN1 levels | PROLV000730 | 2.16 | Protein levels | Hepatocyte | 95 | 3 | 8 | 18 | |
| 355 | C1QTNF1 levels | PROLV000224 | 2.16 | Protein levels | Neural / glial | 27 | 2 | 10 | 34 | |
| 356 | HSPB6 levels | PROLV000998 | 2.15 | Protein levels | Muscle / cardiac | 7 | 4 | 10 | 26 | |
| 357 | COL18A1 levels | PROLV000484 | 2.15 | Protein levels | Stromal / connective | 55 | 3 | 7 | 12 | |
| 358 | BGLAP levels | PROLV000193 | 2.14 | Protein levels | Stromal / connective | 19 | 3 | 7 | 17 | |
| 359 | ALB levels | PROLV000077 | 2.14 | Protein levels | Myeloid | 1,602 | 3 | 15 | 21 | |
| 360 | IDI2 levels | PROLV001010 | 2.13 | Protein levels | Muscle / cardiac | 11 | 3 | 8 | 20 | |
| 361 | ATRN levels | PROLV000163 | 2.13 | Protein levels | Vascular | 52 | 6 | 17 | 29 | |
| 362 | MIA/NBL1 ratio | PRORT001532 | 2.13 | Protein ratios | Stromal / connective | 22 | 3 | 7 | 17 | |
| 363 | CHI3L1/HSPG2 ratio | PRORT000610 | 2.13 | Protein ratios | Hepatocyte | 10 | 2 | 9 | 26 | |
| 364 | ST6GALNAC2 levels | PROLV001954 | 2.12 | Protein levels | Neural / glial | 11 | 3 | 8 | 11 | |
| 365 | ROBO2/SCARF2 ratio | PRORT001745 | 2.12 | Protein ratios | Adipose | 12 | 4 | 10 | 12 | |
| 366 | Biventricular shape | CARDI000010 | 2.12 | Cardiac | Muscle / cardiac | 44 | 2 | 4 | 12 | |
| 367 | CCN3/COL6A3 ratio | PRORT000372 | 2.11 | Protein ratios | Stromal / connective | 26 | 0 | 3 | 5 | |
| 368 | IGDCC4 levels | PROLV001024 | 2.11 | Protein levels | Myeloid | 46 | 4 | 11 | 16 | |
| 369 | ALOX15B levels | PROLV000081 | 2.11 | Protein levels | Lymphocyte | 0 | 6 | 11 | 37 | |
| 370 | AGRN/HSPG2 ratio | PRORT000048 | 2.11 | Protein ratios | Stromal / connective | 22 | 7 | 7 | 25 | |
| 371 | MYOC/RGMB ratio | PRORT001567 | 2.10 | Protein ratios | Vascular | 11 | 2 | 8 | 15 | |
| 372 | Refractive errors | OPHTH000034 | 2.10 | Ophthalmic | Neural / glial | 133 | 1 | 6 | 9 | |
| 373 | HPGDS/ITGAV ratio | PRORT001300 | 2.10 | Protein ratios | Hepatocyte | 10 | 3 | 11 | 27 | |
| 374 | IGSF9 levels | PROLV001040 | 2.09 | Protein levels | Hepatocyte | 63 | 3 | 9 | 17 | |
| 375 | GSTA3 levels | PROLV000940 | 2.09 | Protein levels | Hepatocyte | 38 | 3 | 12 | 25 | |
| 376 | DPP4/ITGB1 ratio | PRORT000944 | 2.08 | Protein ratios | Myeloid | 11 | 3 | 12 | 25 | |
| 377 | CD59/CST6 ratio | PRORT000481 | 2.08 | Protein ratios | Respiratory epithelium | 3 | 0 | 12 | 7 | |
| 378 | CCL11/CCL13 ratio | PRORT000334 | 2.07 | Protein ratios | Myeloid | 9 | 2 | 4 | 10 | |
| 379 | LTBP2 levels | PROLV001242 | 2.07 | Protein levels | Myeloid | 145 | 4 | 14 | 23 | |
| 380 | Isoleucine | METAB000024 | 2.07 | Metabolites | Hepatocyte | 28 | 3 | 6 | 20 | |
| 381 | GSTA4 levels | PROLV000941 | 2.07 | Protein levels | Adipose | 0 | 2 | 16 | 26 | |
| 382 | Creatine kinase | MSKEL000027 | 2.06 | Musculoskeletal | Muscle / cardiac | 145 | 4 | 10 | 21 | |
| 383 | CD109 levels | PROLV000309 | 2.06 | Protein levels | Neural / glial | 31 | 4 | 14 | 36 | |
| 384 | Cerebrovascular disease | VASCU000013 | 2.05 | Vascular | Vascular | 56 | 2 | 6 | 9 | |
| 385 | C2/SSC5D ratio | PRORT000265 | 2.05 | Protein ratios | Vascular | 15 | 1 | 6 | 10 | |
| 386 | Blood pressure, BP, systolic | VASCU000011 | 2.05 | Vascular | Vascular | 1,562 | 4 | 7 | 13 | |
| 387 | RFC4 levels | PROLV001726 | 2.05 | Protein levels | Stromal / connective | 1 | 4 | 14 | 19 | |
| 388 | RBP7 levels | PROLV001713 | 2.04 | Protein levels | Neural / glial | 36 | 3 | 9 | 11 | |
| 389 | ITGBL1 levels | PROLV001117 | 2.03 | Protein levels | Vascular | 82 | 3 | 11 | 14 | |
| 390 | Tonsillar and adenoidal disorders | RESPI000040 | 2.03 | Respiratory | Myeloid | 125 | 2 | 10 | 27 | |
| 391 | MMP10 levels | PROLV001322 | 2.02 | Protein levels | Epithelial | 12 | 0 | 6 | 7 | |
| 392 | CNTN2 levels | PROLV000476 | 2.02 | Protein levels | Vascular | 46 | 4 | 13 | 25 | |
| 393 | BCAN/KLK6 ratio | PRORT000216 | 2.02 | Protein ratios | Myeloid | 11 | 2 | 7 | 12 | |
| 394 | CTSF/SMPDL3A ratio | PRORT000802 | 2.02 | Protein ratios | Hepatocyte | 30 | 1 | 7 | 18 | |
| 395 | NPTXR levels | PROLV001428 | 2.01 | Protein levels | Myeloid | 28 | 1 | 6 | 14 | |
| 396 | CD48 levels | PROLV000343 | 2.01 | Protein levels | B / plasma cell | 92 | 2 | 8 | 19 | |
| 397 | Dihydrosphingomyelins | LIPID000067 | 2.00 | Lipids | Epithelial | 0 | 0 | 6 | 10 | |
| 398 | LEP levels | PROLV001199 | 2.00 | Protein levels | Neural / glial | 1 | 0 | 8 | 12 | |
| 399 | FCN1 levels | PROLV000781 | 2.00 | Protein levels | Myeloid | 95 | 2 | 8 | 18 | |
| 400 | BCAM/CDH5 ratio | PRORT000206 | 1.99 | Protein ratios | Vascular | 42 | 1 | 12 | 12 | |
| 401 | Valine | METAB000032 | 1.99 | Metabolites | Hepatocyte | 209 | 2 | 6 | 18 | |
| 402 | Coagulation disorder | HEMAT000017 | 1.99 | Hematologic | Stromal / connective | 25 | 1 | 3 | 10 | |
| 403 | CA1/TGM2 ratio | PRORT000270 | 1.99 | Protein ratios | Hematopoietic progenitor | 1 | 6 | 9 | 12 | |
| 404 | Cardiac implants and grafts | CARDI000048 | 1.99 | Cardiac | Vascular | 36 | 4 | 9 | 23 | |
| 405 | Gynaecomastia | BREAS000003 | 1.98 | Breast | Granulosa cell | 0 | 1 | 4 | 11 | |
| 406 | Jaw relationship anomaly | DENTA000007 | 1.98 | Dental | Neural / glial | 0 | 1 | 5 | 12 | |
| 407 | APOA4 levels | PROLV000119 | 1.98 | Protein levels | Granulosa cell | 12 | 0 | 5 | 7 | |
| 408 | ITGAM levels | PROLV001109 | 1.97 | Protein levels | Myeloid | 94 | 2 | 11 | 15 | |
| 409 | Ischaemic heart disease | CARDI000041 | 1.97 | Cardiac | Vascular | 595 | 3 | 10 | 19 | |
| 410 | CSF1/LTBR ratio | PRORT000778 | 1.96 | Protein ratios | Myeloid | 29 | 5 | 13 | 24 | |
| 411 | IGFBP3 levels | PROLV001030 | 1.96 | Protein levels | Hepatocyte | 67 | 2 | 10 | 17 | |
| 412 | ERBIN/SNAP29 ratio | PRORT001051 | 1.96 | Protein ratios | Muscle / cardiac | 0 | 3 | 9 | 18 | |
| 413 | Ganglion cell inner plexiform layer thickness | OPHTH000027 | 1.96 | Ophthalmic | Renal epithelium | 10 | 0 | 6 | 5 | |
| 414 | Macular degeneration | OPHTH000036 | 1.96 | Ophthalmic | Hepatocyte | 106 | 2 | 7 | 15 | |
| 415 | Myocardial infarction | CARDI000042 | 1.96 | Cardiac | Vascular | 343 | 3 | 9 | 12 | |
| 416 | AKT1S1/MAX ratio | PRORT000065 | 1.96 | Protein ratios | Myeloid | 3 | 3 | 10 | 12 | |
| 417 | CST3/EFEMP1 ratio | PRORT000782 | 1.95 | Protein ratios | Hepatocyte | 26 | 1 | 6 | 15 | |
| 418 | ORM1 levels | PROLV001473 | 1.95 | Protein levels | Myeloid | 16 | 1 | 9 | 12 | |
| 419 | EIF4G1/MAVS ratio | PRORT001011 | 1.95 | Protein ratios | Myeloid | 22 | 3 | 9 | 16 | |
| 420 | Arterial stiffness | VASCU000050 | 1.95 | Vascular | Stromal / connective | 3 | 2 | 3 | 12 | |
| 421 | EGF/TNFSF14 ratio | PRORT000999 | 1.95 | Protein ratios | Hepatocyte | 12 | 4 | 17 | 36 | |
| 422 | Ventricular mass-to-volume ratio | CARDI000013 | 1.94 | Cardiac | Muscle / cardiac | 40 | 3 | 5 | 17 | |
| 423 | PRR4 levels | PROLV001642 | 1.94 | Protein levels | Epithelial | 44 | 0 | 8 | 9 | |
| 424 | HSPG2/SMOC2 ratio | PRORT001309 | 1.94 | Protein ratios | Stromal / connective | 32 | 4 | 9 | 16 | |
| 425 | CA5A/KRT18 ratio | PRORT000288 | 1.94 | Protein ratios | Hepatocyte | 18 | 1 | 10 | 19 | |
| 426 | TNFRSF10A levels | PROLV002057 | 1.94 | Protein levels | Myeloid | 46 | 1 | 7 | 5 | |
| 427 | RBP5 levels | PROLV001712 | 1.93 | Protein levels | Adipose | 3 | 0 | 8 | 32 | |
| 428 | CLEC10A levels | PROLV000444 | 1.92 | Protein levels | Myeloid | 116 | 2 | 8 | 14 | |
| 429 | Mammary dysplasia | BREAS000001 | 1.92 | Breast | Adipose | 0 | 1 | 8 | 17 | |
| 430 | C19ORF12 levels | PROLV000221 | 1.92 | Protein levels | Hepatocyte | 48 | 1 | 6 | 23 | |
| 431 | CD177 levels | PROLV000314 | 1.91 | Protein levels | Myeloid | 21 | 1 | 6 | 7 | |
| 432 | CES1 levels | PROLV000405 | 1.90 | Protein levels | Hepatocyte | 148 | 1 | 8 | 13 | |
| 433 | HSD11B1/SMPD1 ratio | PRORT001302 | 1.90 | Protein ratios | Hepatocyte | 78 | 1 | 6 | 17 | |
| 434 | MSR1/TNFRSF21 ratio | PRORT001560 | 1.90 | Protein ratios | Myeloid | 29 | 3 | 12 | 12 | |
| 435 | External ear disorder | AUDIO000001 | 1.89 | Auditory | Hepatocyte | 0 | 2 | 8 | 19 | |
| 436 | NBL1/TGFBR2 ratio | PRORT001573 | 1.89 | Protein ratios | Vascular | 18 | 1 | 7 | 15 | |
| 437 | CLEC14A/EPHB4 ratio | PRORT000626 | 1.89 | Protein ratios | Vascular | 10 | 3 | 7 | 17 | |
| 438 | BAX levels | PROLV000180 | 1.89 | Protein levels | Vascular | 2 | 5 | 7 | 20 | |
| 439 | LCN2/S100A12 ratio | PRORT001444 | 1.89 | Protein ratios | Myeloid | 28 | 4 | 18 | 35 | |
| 440 | Triglycerides/phosphoglycerides | LIPID000042 | 1.89 | Lipids | Hepatocyte | 839 | 3 | 8 | 17 | |
| 441 | PINLYP levels | PROLV001562 | 1.88 | Protein levels | Myeloid | 66 | 4 | 10 | 14 | |
| 442 | FLT1/TFPI2 ratio | PRORT001162 | 1.88 | Protein ratios | Myeloid | 3 | 5 | 11 | 21 | |
| 443 | Phenylalanine | METAB000027 | 1.88 | Metabolites | Hepatocyte | 104 | 1 | 4 | 10 | |
| 444 | Osteomyelitis | IMMUN000068 | 1.88 | Immunologic | Stromal / connective | 19 | 2 | 4 | 5 | |
| 445 | BTD levels | PROLV000218 | 1.87 | Protein levels | Hepatocyte | 77 | 3 | 11 | 13 | |
| 446 | ANXA3/ENO2 ratio | PRORT000106 | 1.87 | Protein ratios | Hematopoietic progenitor | 1 | 3 | 6 | 13 | |
| 447 | FCRL2/KLB ratio | PRORT001129 | 1.86 | Protein ratios | Hepatocyte | 35 | 1 | 5 | 11 | |
| 448 | PLG levels | PROLV001577 | 1.86 | Protein levels | Granulosa cell | 46 | 5 | 14 | 28 | |
| 449 | HLA-E levels | PROLV000976 | 1.86 | Protein levels | Stromal / connective | 104 | 1 | 7 | 30 | |
| 450 | APOA levels | PROLV000116 | 1.86 | Protein levels | Hepatocyte | 1,456 | 3 | 9 | 17 | |
| 451 | IL31RA levels | PROLV001071 | 1.86 | Protein levels | Granulosa cell | 1 | 3 | 7 | 13 | |
| 452 | Ganglion cyst | MSKEL000065 | 1.86 | Musculoskeletal | Stromal / connective | 0 | 1 | 3 | 12 | |
| 453 | SEMA4D/TXNDC5 ratio | PRORT001772 | 1.86 | Protein ratios | Stromal / connective | 0 | 3 | 6 | 14 | |
| 454 | Fracture | MSKEL000011 | 1.86 | Musculoskeletal | Stromal / connective | 27 | 1 | 1 | 1 | |
| 455 | Spine surgery | MSKEL000051 | 1.85 | Musculoskeletal | Stromal / connective | 0 | 2 | 7 | 14 | |
| 456 | Intestinal infection | IMMUN000066 | 1.85 | Immunologic | Vascular | 5 | 3 | 7 | 15 | |
| 457 | CCL27 levels | PROLV000294 | 1.84 | Protein levels | Myeloid | 146 | 2 | 10 | 16 | |
| 458 | DPP4 levels | PROLV000646 | 1.84 | Protein levels | Myeloid | 44 | 3 | 12 | 22 | |
| 459 | CLSTN2/MATN2 ratio | PRORT000676 | 1.84 | Protein ratios | Hepatocyte | 25 | 2 | 8 | 16 | |
| 460 | FAM3B/FGF19 ratio | PRORT001111 | 1.84 | Protein ratios | Hepatocyte | 18 | 2 | 7 | 14 | |
| 461 | RNASE4 levels | PROLV001739 | 1.83 | Protein levels | Hepatocyte | 43 | 2 | 7 | 16 | |
| 462 | Leucine | METAB000025 | 1.83 | Metabolites | Hepatocyte | 24 | 3 | 8 | 21 | |
| 463 | CDON/SCARA5 ratio | PRORT000581 | 1.82 | Protein ratios | Adipose | 51 | 3 | 7 | 11 | |
| 464 | Branched-chain amino acids | METAB000019 | 1.82 | Metabolites | Hepatocyte | 32 | 3 | 9 | 16 | |
| 465 | FSTL3/SPON2 ratio | PRORT001182 | 1.82 | Protein ratios | Hepatocyte | 3 | 2 | 9 | 23 | |
| 466 | ADAMTS8/FAP ratio | PRORT000026 | 1.82 | Protein ratios | Muscle / cardiac | 0 | 2 | 4 | 7 | |
| 467 | APOM/MCAM ratio | PRORT000119 | 1.82 | Protein ratios | Hepatocyte | 64 | 2 | 10 | 18 | |
| 468 | THBS4 levels | PROLV002027 | 1.82 | Protein levels | Hepatocyte | 69 | 2 | 8 | 18 | |
| 469 | SVEP1 levels | PROLV001982 | 1.81 | Protein levels | Vascular | 7 | 2 | 7 | 4 | |
| 470 | TNN levels | PROLV002083 | 1.81 | Protein levels | Stromal / connective | 16 | 2 | 9 | 11 | |
| 471 | DDHD2 levels | PROLV000609 | 1.81 | Protein levels | Vascular | 9 | 4 | 10 | 15 | |
| 472 | EPCAM levels | PROLV000715 | 1.81 | Protein levels | Vascular | 30 | 1 | 7 | 12 | |
| 473 | HYOU1/TGFBR3 ratio | PRORT001317 | 1.81 | Protein ratios | Hepatocyte | 27 | 2 | 8 | 23 | |
| 474 | Pregnancy complication, haemorrhage | REPRO000030 | 1.80 | Reproductive | Stromal / connective | 13 | 2 | 3 | 14 | |
| 475 | Circulatory disorder | VASCU000025 | 1.80 | Vascular | Neural / glial | 1 | 1 | 5 | 14 | |
| 476 | NOS3 levels | PROLV001415 | 1.80 | Protein levels | Myeloid | 58 | 5 | 9 | 18 | |
| 477 | Chronic kidney disease | NEPHR000001 | 1.79 | Nephrourologic | Hepatocyte | 63 | 1 | 4 | 8 | |
| 478 | CCL22/TIMP3 ratio | PRORT000352 | 1.79 | Protein ratios | Vascular | 5 | 2 | 7 | 19 | |
| 479 | Uterine or vaginal bleeding | REPRO000044 | 1.79 | Reproductive | Stromal / connective | 0 | 5 | 8 | 16 | |
| 480 | ITGAM/ITGAV ratio | PRORT001375 | 1.79 | Protein ratios | Myeloid | 72 | 4 | 16 | 25 | |
| 481 | NCAM1 levels | PROLV001377 | 1.79 | Protein levels | Muscle / cardiac | 119 | 4 | 11 | 24 | |
| 482 | ICAM2 levels | PROLV001005 | 1.78 | Protein levels | Vascular | 38 | 4 | 7 | 20 | |
| 483 | CLUL1 levels | PROLV000468 | 1.78 | Protein levels | Hepatocyte | 71 | 4 | 9 | 27 | |
| 484 | Nephritis and nephropathy | NEPHR000010 | 1.78 | Nephrourologic | Muscle / cardiac | 0 | 1 | 4 | 7 | |
| 485 | Eye disorder, none | OPHTH000007 | 1.78 | Ophthalmic | Neural / glial | — | 4 | 14 | 11 | |
| 486 | DSG4 levels | PROLV000657 | 1.77 | Protein levels | Cutaneous epithelium | 24 | 1 | 7 | 10 | |
| 487 | IFNGR2 levels | PROLV001021 | 1.77 | Protein levels | Myeloid | 122 | 5 | 14 | 30 | |
| 488 | TNFRSF19 levels | PROLV002067 | 1.77 | Protein levels | Muscle / cardiac | 8 | 1 | 8 | 14 | |
| 489 | IGFBP4/OGN ratio | PRORT001335 | 1.77 | Protein ratios | Stromal / connective | 0 | 2 | 11 | 29 | |
| 490 | ROR1 levels | PROLV001751 | 1.77 | Protein levels | Hepatocyte | 77 | 1 | 4 | 10 | |
| 491 | Migraine | NEURO000010 | 1.76 | Neurologic | Neural / glial | 16 | 0 | 1 | 5 | |
| 492 | Hydrocephalus | NEURO000002 | 1.76 | Neurologic | Stromal / connective | 10 | 2 | 4 | 16 | |
| 493 | GFAP levels | PROLV000874 | 1.76 | Protein levels | Myeloid | 2 | 3 | 11 | 10 | |
| 494 | PLA2G4A/SNAP29 ratio | PRORT001675 | 1.75 | Protein ratios | Platelet | 13 | 3 | 7 | 22 | |
| 495 | LRP11 levels | PROLV001230 | 1.75 | Protein levels | Vascular | 22 | 0 | 8 | 22 | |
| 496 | Intestinal disorder | GASTR000012 | 1.75 | Gastrointestinal | Neural / glial | 8 | 2 | 6 | 13 | |
| 497 | CD84/GP1BA ratio | PRORT000524 | 1.75 | Protein ratios | Vascular | 17 | 2 | 10 | 19 | |
| 498 | FOXO3/MAP3K5 ratio | PRORT001178 | 1.75 | Protein ratios | Gastrointestinal epithelium | 0 | 1 | 11 | 19 | |
| 499 | IGSF3 levels | PROLV001038 | 1.75 | Protein levels | Hepatocyte | 95 | 2 | 8 | 28 | |
| 500 | LY6D/PLA2G10 ratio | PRORT001469 | 1.75 | Protein ratios | Vascular | 48 | 3 | 10 | 17 | |
| 501 | HEPH levels | PROLV000963 | 1.74 | Protein levels | Lymphocyte | 12 | 0 | 9 | 27 | |
| 502 | ESAM/TGFB1 ratio | PRORT001067 | 1.74 | Protein ratios | Muscle / cardiac | 20 | 4 | 11 | 17 | |
| 503 | MB levels | PROLV001281 | 1.74 | Protein levels | Muscle / cardiac | 26 | 3 | 4 | 11 | |
| 504 | Shift work | SOCIO000008 | 1.74 | Socioeconomic | Granulosa cell | 0 | 1 | 4 | 18 | |
| 505 | Optic disc area | OPHTH000029 | 1.74 | Ophthalmic | Vascular | 11 | 4 | 7 | 13 | |
| 506 | Headache | NEURO000009 | 1.74 | Neurologic | Neural / glial | 18 | 1 | 5 | 18 | |
| 507 | FIS1/PDGFB ratio | PRORT001150 | 1.74 | Protein ratios | Myeloid | 14 | 2 | 8 | 23 | |
| 508 | COLEC12/LTBR ratio | PRORT000703 | 1.73 | Protein ratios | Myeloid | 50 | 3 | 7 | 12 | |
| 509 | DNAJC9 levels | PROLV000636 | 1.73 | Protein levels | Muscle / cardiac | 1 | 2 | 11 | 35 | |
| 510 | GBP2 levels | PROLV000861 | 1.73 | Protein levels | Myeloid | 0 | 2 | 11 | 16 | |
| 511 | Gut microbial abundance, Olsenella C | GASTR000030 | 1.73 | Gastrointestinal | Vascular | 0 | 4 | 10 | 24 | |
| 512 | ICAM5 levels | PROLV001008 | 1.73 | Protein levels | Myeloid | 6 | 0 | 3 | 9 | |
| 513 | PTPRF/PTPRS ratio | PRORT001721 | 1.73 | Protein ratios | Hepatocyte | 76 | 4 | 11 | 24 | |
| 514 | Ventricular volume | CARDI000015 | 1.73 | Cardiac | Muscle / cardiac | 83 | 2 | 7 | 15 | |
| 515 | COL3A1 levels | PROLV000489 | 1.73 | Protein levels | Myeloid | 15 | 4 | 10 | 22 | |
| 516 | ERBB3 levels | PROLV000725 | 1.73 | Protein levels | Hepatocyte | 97 | 4 | 10 | 20 | |
| 517 | SRPX levels | PROLV001945 | 1.73 | Protein levels | Adipose | 32 | 4 | 10 | 16 | |
| 518 | FGF5 levels | PROLV000797 | 1.73 | Protein levels | Hepatocyte | 31 | 3 | 5 | 10 | |
| 519 | Premature cardiac beat | CARDI000023 | 1.72 | Cardiac | Neural / glial | 0 | 3 | 12 | 20 | |
| 520 | LTBP2/MYOC ratio | PRORT001464 | 1.72 | Protein ratios | Neural / glial | 0 | 3 | 8 | 16 | |
| 521 | APOM/ERBB3 ratio | PRORT000118 | 1.71 | Protein ratios | Hepatocyte | 22 | 1 | 9 | 15 | |
| 522 | TXN levels | PROLV002123 | 1.71 | Protein levels | Lymphocyte | 1 | 3 | 11 | 28 | |
| 523 | Nerve root disorder | NEURO000030 | 1.71 | Neurologic | Stromal / connective | 3 | 2 | 5 | 15 | |
| 524 | NAAA levels | PROLV001369 | 1.70 | Protein levels | Hepatocyte | 124 | 1 | 5 | 11 | |
| 525 | Intervertebral disc disorder | MSKEL000076 | 1.70 | Musculoskeletal | Stromal / connective | 31 | 2 | 6 | 23 | |
| 526 | GZMA/TNFRSF4 ratio | PRORT001261 | 1.69 | Protein ratios | Lymphocyte | 36 | 3 | 15 | 35 | |
| 527 | GLB1/IMPA1 ratio | PRORT001216 | 1.69 | Protein ratios | Myeloid | 65 | 4 | 11 | 19 | |
| 528 | CDCP1/MSR1 ratio | PRORT000544 | 1.69 | Protein ratios | Myeloid | 26 | 2 | 10 | 13 | |
| 529 | ACYP1 levels | PROLV000021 | 1.69 | Protein levels | Lymphocyte | 14 | 2 | 12 | 34 | |
| 530 | Gut microbial abundance, Massiliomicrobiota | GASTR000028 | 1.69 | Gastrointestinal | Renal epithelium | 0 | 0 | 8 | 8 | |
| 531 | FCGR3B levels | PROLV000780 | 1.69 | Protein levels | Myeloid | 115 | 2 | 9 | 12 | |
| 532 | NELL2 levels | PROLV001391 | 1.68 | Protein levels | Myeloid | 146 | 3 | 14 | 20 | |
| 533 | CLMP/GFRA1 ratio | PRORT000668 | 1.68 | Protein ratios | Hepatocyte | 49 | 2 | 9 | 18 | |
| 534 | COMP/ICAM1 ratio | PRORT000710 | 1.68 | Protein ratios | Myeloid | 38 | 4 | 10 | 17 | |
| 535 | Nasal septum deviation | RESPI000038 | 1.68 | Respiratory | Epithelial | 1 | 2 | 14 | 15 | |
| 536 | ADAMTSL4 levels | PROLV000037 | 1.68 | Protein levels | Myeloid | 49 | 3 | 12 | 24 | |
| 537 | NXPH3 levels | PROLV001458 | 1.67 | Protein levels | Stromal / connective | 3 | 1 | 4 | 15 | |
| 538 | ERBIN/TBC1D23 ratio | PRORT001052 | 1.66 | Protein ratios | Hepatocyte | 0 | 4 | 9 | 17 | |
| 539 | CTSL levels | PROLV000566 | 1.65 | Protein levels | Myeloid | 163 | 2 | 9 | 15 | |
| 540 | IL10RB levels | PROLV001043 | 1.65 | Protein levels | Granulosa cell | 21 | 1 | 8 | 7 | |
| 541 | GRAP2/PLPBP ratio | PRORT001242 | 1.65 | Protein ratios | Hepatocyte | 1 | 3 | 8 | 17 | |
| 542 | PDCD6 levels | PROLV001518 | 1.65 | Protein levels | Muscle / cardiac | 54 | 3 | 13 | 24 | |
| 543 | Intrahepatic cholestasis of pregnancy, ICP | HPBIL000001 | 1.64 | Hepatopancreatobiliary | Hepatocyte | 97 | 1 | 6 | 8 | |
| 544 | CGREF1/FAM3C ratio | PRORT000609 | 1.64 | Protein ratios | Hepatocyte | 2 | 0 | 4 | 8 | |
| 545 | AZU1 levels | PROLV000168 | 1.64 | Protein levels | Muscle / cardiac | 18 | 3 | 4 | 8 | |
| 546 | SFRP2 levels | PROLV001845 | 1.64 | Protein levels | Neural / glial | 11 | 4 | 8 | 24 | |
| 547 | FSHB levels | PROLV000828 | 1.64 | Protein levels | Myeloid | 0 | 1 | 7 | 14 | |
| 548 | CEACAM19 levels | PROLV000389 | 1.64 | Protein levels | Cutaneous epithelium | 26 | 1 | 9 | 8 | |
| 549 | CIAPIN1/SNX9 ratio | PRORT000617 | 1.64 | Protein ratios | Vascular | 0 | 4 | 15 | 42 | |
| 550 | Medication, chronic lung disease | RESPI000006 | 1.64 | Respiratory | Neural / glial | 4 | 3 | 21 | 50 | |
| 551 | AARSD1/UBAC1 ratio | PRORT000002 | 1.63 | Protein ratios | Muscle / cardiac | 0 | 3 | 6 | 13 | |
| 552 | FGFR2 levels | PROLV000801 | 1.63 | Protein levels | Adipose | 45 | 0 | 5 | 11 | |
| 553 | MPO levels | PROLV001336 | 1.63 | Protein levels | Myeloid | 55 | 2 | 5 | 10 | |
| 554 | DCTN1/FXN ratio | PRORT000872 | 1.63 | Protein ratios | Hepatocyte | 0 | 4 | 15 | 34 | |
| 555 | CHCHD6 levels | PROLV000425 | 1.63 | Protein levels | Stromal / connective | 0 | 3 | 8 | 26 | |
| 556 | Operation, respiratory | RESPI000025 | 1.63 | Respiratory | Vascular | 61 | 3 | 12 | 22 | |
| 557 | Body fat percentage, hormone-adjusted | BCOMP000001 | 1.63 | Body composition | Hepatocyte | 237 | 2 | 6 | 9 | |
| 558 | NUCB2/TXNDC5 ratio | PRORT001608 | 1.62 | Protein ratios | Hepatocyte | 4 | 3 | 8 | 13 | |
| 559 | COLEC12 levels | PROLV000494 | 1.62 | Protein levels | Stromal / connective | 9 | 1 | 4 | 6 | |
| 560 | TIMM8A levels | PROLV002037 | 1.62 | Protein levels | Vascular | 17 | 4 | 8 | 16 | |
| 561 | Triglycerides/HDL cholesterol | LIPID000041 | 1.62 | Lipids | Hepatocyte | 792 | 3 | 9 | 19 | |
| 562 | CCL8 levels | PROLV000300 | 1.61 | Protein levels | Myeloid | 76 | 2 | 6 | 14 | |
| 563 | PLA2G10 levels | PROLV001565 | 1.61 | Protein levels | Hepatocyte | 100 | 2 | 9 | 13 | |
| 564 | PI16 levels | PROLV001553 | 1.61 | Protein levels | Myeloid | 144 | 1 | 6 | 16 | |
| 565 | CD84 levels | PROLV000359 | 1.61 | Protein levels | Neural / glial | 16 | 3 | 10 | 8 | |
| 566 | NBL1 levels | PROLV001375 | 1.60 | Protein levels | Renal epithelium | 28 | 0 | 4 | 2 | |
| 567 | PTPRS levels | PROLV001681 | 1.60 | Protein levels | Lymphocyte | 21 | 2 | 9 | 37 | |
| 568 | ARF6 levels | PROLV000133 | 1.60 | Protein levels | Stromal / connective | 50 | 5 | 15 | 21 | |
| 569 | Benign neoplasm, Colorectal | MALIG000002 | 1.60 | Malignancy | Stromal / connective | 41 | 0 | 4 | 4 | |
| 570 | Knee extension strength | MSKEL000031 | 1.60 | Musculoskeletal | Stromal / connective | 0 | 2 | 6 | 10 | |
| 571 | Gastric ulcer | GASTR000048 | 1.60 | Gastrointestinal | Lymphocyte | 3 | 1 | 7 | 27 | |
| 572 | JAM2/RGMB ratio | PRORT001396 | 1.60 | Protein ratios | Vascular | 2 | 2 | 6 | 11 | |
| 573 | DLL1/EFEMP1 ratio | PRORT000914 | 1.60 | Protein ratios | Hepatocyte | 33 | 2 | 7 | 20 | |
| 574 | Low hand grip strength | MSKEL000032 | 1.59 | Musculoskeletal | Muscle / cardiac | 1 | 4 | 10 | 21 | |
| 575 | COL15A1 levels | PROLV000483 | 1.59 | Protein levels | Stromal / connective | 4 | 0 | 6 | 11 | |
| 576 | CD40LG/SERPINE1 ratio | PRORT000453 | 1.59 | Protein ratios | Hematopoietic progenitor | 2 | 2 | 9 | 18 | |
| 577 | PMVK levels | PROLV001590 | 1.59 | Protein levels | Myeloid | 34 | 3 | 8 | 12 | |
| 578 | FKBP5/TBCC ratio | PRORT001159 | 1.59 | Protein ratios | Hepatocyte | 10 | 1 | 8 | 14 | |
| 579 | GHR levels | PROLV000885 | 1.58 | Protein levels | Hepatocyte | 17 | 2 | 7 | 23 | |
| 580 | Citrate | METAB000065 | 1.58 | Metabolites | Hepatocyte | 316 | 2 | 9 | 21 | |
| 581 | PTPRH levels | PROLV001676 | 1.58 | Protein levels | Vascular | 69 | 3 | 7 | 15 | |
| 582 | CD69/CDKN2D ratio | PRORT000487 | 1.58 | Protein ratios | Vascular | 6 | 3 | 8 | 16 | |
| 583 | DAPP1 levels | PROLV000594 | 1.58 | Protein levels | Stromal / connective | 37 | 2 | 6 | 13 | |
| 584 | COLEC12/TGFBR2 ratio | PRORT000707 | 1.58 | Protein ratios | Hepatocyte | 75 | 3 | 8 | 18 | |
| 585 | CD200R1 levels | PROLV000317 | 1.58 | Protein levels | Adipose | 54 | 2 | 5 | 14 | |
| 586 | IFNGR1 levels | PROLV001020 | 1.57 | Protein levels | Myeloid | 139 | 1 | 7 | 10 | |
| 587 | LRIG1 levels | PROLV001227 | 1.57 | Protein levels | Hepatocyte | 171 | 3 | 11 | 24 | |
| 588 | PTGR1 levels | PROLV001666 | 1.57 | Protein levels | Hepatocyte | 38 | 3 | 11 | 18 | |
| 589 | Peripheral vascular disease | VASCU000043 | 1.57 | Vascular | Stromal / connective | 65 | 3 | 6 | 14 | |
| 590 | PRTFDC1 levels | PROLV001649 | 1.56 | Protein levels | Platelet | 28 | 3 | 11 | 12 | |
| 591 | Mononeuropathy | NEURO000027 | 1.56 | Neurologic | Stromal / connective | 2 | 0 | 0 | 3 | |
| 592 | SOD3 levels | PROLV001918 | 1.56 | Protein levels | Myeloid | 84 | 3 | 9 | 10 | |
| 593 | Valvular heart disease | CARDI000054 | 1.56 | Cardiac | Vascular | 15 | 5 | 9 | 24 | |
| 594 | FABP5 levels | PROLV000755 | 1.55 | Protein levels | Stromal / connective | 7 | 5 | 11 | 35 | |
| 595 | NAAA/SMPD1 ratio | PRORT001569 | 1.55 | Protein ratios | Granulosa cell | 6 | 3 | 12 | 20 | |
| 596 | Breast disorder | BREAS000002 | 1.55 | Breast | Respiratory epithelium | 0 | 0 | 11 | 13 | |
| 597 | Hip circumference | BMORP000011 | 1.55 | Body morphology | Neural / glial | 496 | 4 | 9 | 26 | |
| 598 | SLITRK6 levels | PROLV001890 | 1.55 | Protein levels | Adipose | 4 | 2 | 11 | 17 | |
| 599 | IL13RA1 levels | PROLV001047 | 1.54 | Protein levels | Hepatocyte | 1 | 3 | 10 | 21 | |
| 600 | Bone marrow fat fraction, spine | MSKEL000002 | 1.54 | Musculoskeletal | Vascular | 67 | 2 | 8 | 16 | |
| 601 | Medication, GERD | GASTR000014 | 1.54 | Gastrointestinal | Neural / glial | 1 | 2 | 7 | 12 | |
| 602 | MXRA8 levels | PROLV001355 | 1.54 | Protein levels | Myeloid | 78 | 5 | 12 | 24 | |
| 603 | OGN levels | PROLV001465 | 1.54 | Protein levels | Epithelial | 12 | 0 | 9 | 4 | |
| 604 | COQ7 levels | PROLV000498 | 1.53 | Protein levels | Hepatocyte | 59 | 1 | 6 | 7 | |
| 605 | Alport syndrome | NEPHR000003 | 1.53 | Nephrourologic | Lymphocyte | 3 | 3 | 4 | 20 | |
| 606 | PRAP1 levels | PROLV001623 | 1.53 | Protein levels | Hematopoietic progenitor | 16 | 2 | 6 | 11 | |
| 607 | Retinal thickness | OPHTH000043 | 1.53 | Ophthalmic | Neural / glial | 58 | 1 | 5 | 7 | |
| 608 | Brain age gap | NIMAG000004 | 1.53 | Neuroimaging | Neural / glial | 1 | 4 | 15 | 36 | |
| 609 | DSCAM levels | PROLV000654 | 1.52 | Protein levels | Myeloid | 110 | 4 | 10 | 20 | |
| 610 | SOD2 levels | PROLV001917 | 1.52 | Protein levels | Myeloid | 96 | 2 | 6 | 7 | |
| 611 | Peripheral artery disease | VASCU000042 | 1.52 | Vascular | Vascular | 44 | 3 | 9 | 23 | |
| 612 | PTPRZ1 levels | PROLV001682 | 1.52 | Protein levels | Myeloid | 82 | 3 | 10 | 17 | |
| 613 | Triglycerides, HDL | LIPID000033 | 1.52 | Lipids | Hepatocyte | 1,558 | 3 | 8 | 16 | |
| 614 | SELE levels | PROLV001803 | 1.52 | Protein levels | Vascular | 55 | 2 | 4 | 14 | |
| 615 | PGLS levels | PROLV001545 | 1.52 | Protein levels | Neural / glial | 0 | 5 | 6 | 27 | |
| 616 | Gastrointestinal polyps | GASTR000005 | 1.52 | Gastrointestinal | Respiratory epithelium | 0 | 0 | 4 | 11 | |
| 617 | PLAT levels | PROLV001571 | 1.51 | Protein levels | Hepatocyte | 64 | 2 | 8 | 18 | |
| 618 | CLEC3B levels | PROLV000449 | 1.51 | Protein levels | Vascular | 23 | 3 | 7 | 16 | |
| 619 | GSR levels | PROLV000938 | 1.51 | Protein levels | Myeloid | 12 | 3 | 11 | 26 | |
| 620 | MEGF9 levels | PROLV001294 | 1.51 | Protein levels | Hepatocyte | 93 | 2 | 11 | 23 | |
| 621 | VWF levels | PROLV002182 | 1.51 | Protein levels | Vascular | 12 | 2 | 5 | 13 | |
| 622 | Acute appendicitis | GASTR000009 | 1.50 | Gastrointestinal | Myeloid | 28 | 1 | 2 | 7 | |
| 623 | CPXM1/LGMN ratio | PRORT000734 | 1.50 | Protein ratios | Platelet | 10 | 3 | 6 | 11 | |
| 624 | ATP5IF1/FIS1 ratio | PRORT000156 | 1.50 | Protein ratios | Myeloid | 28 | 3 | 11 | 12 | |
| 625 | CSPG4 levels | PROLV000546 | 1.50 | Protein levels | Myeloid | 93 | 3 | 12 | 18 | |
| 626 | IL19 levels | PROLV001058 | 1.49 | Protein levels | Vascular | 20 | 0 | 7 | 23 | |
| 627 | DAB2/TBL1X ratio | PRORT000841 | 1.49 | Protein ratios | Granulosa cell | 1 | 5 | 12 | 35 | |
| 628 | IGFBPL1 levels | PROLV001034 | 1.49 | Protein levels | Hepatocyte | 26 | 1 | 4 | 8 | |
| 629 | FAM3C/NECTIN2 ratio | PRORT001115 | 1.49 | Protein ratios | Vascular | 19 | 1 | 12 | 10 | |
| 630 | DNER levels | PROLV000637 | 1.49 | Protein levels | Vascular | 69 | 1 | 6 | 18 | |
| 631 | CA6 levels | PROLV000247 | 1.48 | Protein levels | Myeloid | 51 | 2 | 14 | 21 | |
| 632 | MFAP5 levels | PROLV001306 | 1.48 | Protein levels | Vascular | 14 | 2 | 7 | 13 | |
| 633 | GALNT10/IGSF3 ratio | PRORT001201 | 1.48 | Protein ratios | Hepatocyte | 8 | 3 | 11 | 21 | |
| 634 | SCG3 levels | PROLV001785 | 1.48 | Protein levels | Vascular | 110 | 0 | 8 | 11 | |
| 635 | IL1B levels | PROLV001059 | 1.48 | Protein levels | Myeloid | 2 | 3 | 11 | 18 | |
| 636 | MPI/TACC3 ratio | PRORT001556 | 1.48 | Protein ratios | Hematopoietic progenitor | 0 | 2 | 6 | 5 | |
| 637 | CLEC5A levels | PROLV000455 | 1.47 | Protein levels | Myeloid | 94 | 2 | 9 | 10 | |
| 638 | GLOD4/HSPA1A ratio | PRORT001218 | 1.47 | Protein ratios | Myeloid | 20 | 4 | 13 | 19 | |
| 639 | CD99/MMP3 ratio | PRORT000535 | 1.47 | Protein ratios | Hepatocyte | 6 | 1 | 7 | 14 | |
| 640 | PON1 levels | PROLV001600 | 1.47 | Protein levels | Granulosa cell | 40 | 5 | 14 | 21 | |
| 641 | Stroke | VASCU000017 | 1.47 | Vascular | Vascular | 37 | 2 | 4 | 11 | |
| 642 | KRT18 levels | PROLV001165 | 1.47 | Protein levels | Hepatocyte | 62 | 1 | 9 | 29 | |
| 643 | PFDN5 levels | PROLV001539 | 1.47 | Protein levels | Muscle / cardiac | 0 | 4 | 9 | 24 | |
| 644 | Medication, antiplatelet | VASCU000032 | 1.47 | Vascular | Vascular | 78 | 1 | 5 | 9 | |
| 645 | CFB levels | PROLV000410 | 1.47 | Protein levels | Hepatocyte | 101 | 4 | 14 | 24 | |
| 646 | AAMDC levels | PROLV000004 | 1.47 | Protein levels | Myeloid | 19 | 1 | 5 | 7 | |
| 647 | Blood pressure, BP, diastolic | VASCU000009 | 1.47 | Vascular | Vascular | 1,488 | 3 | 6 | 10 | |
| 648 | Viral haemorrhagic fever | IMMUN000075 | 1.46 | Immunologic | Muscle / cardiac | 13 | 2 | 10 | 31 | |
| 649 | RAD23B levels | PROLV001703 | 1.46 | Protein levels | Stromal / connective | 1 | 4 | 9 | 14 | |
| 650 | Shoulder lesion | MSKEL000068 | 1.46 | Musculoskeletal | B / plasma cell | 22 | 1 | 5 | 15 | |
| 651 | TNFRSF12A levels | PROLV002062 | 1.46 | Protein levels | Epithelial | 11 | 0 | 7 | 6 | |
| 652 | TNFSF11 levels | PROLV002076 | 1.46 | Protein levels | Hepatocyte | 28 | 3 | 10 | 14 | |
| 653 | ADAM22 levels | PROLV000027 | 1.45 | Protein levels | Adipose | 54 | 0 | 6 | 8 | |
| 654 | DNAJA2/HPCAL1 ratio | PRORT000922 | 1.45 | Protein ratios | Myeloid | 2 | 5 | 16 | 37 | |
| 655 | AIFM1/EGF ratio | PRORT000059 | 1.45 | Protein ratios | Hepatocyte | 15 | 2 | 10 | 20 | |
| 656 | CCL17/CCL22 ratio | PRORT000342 | 1.45 | Protein ratios | Muscle / cardiac | 3 | 4 | 10 | 31 | |
| 657 | PRUNE2 levels | PROLV001652 | 1.45 | Protein levels | Hepatocyte | 23 | 1 | 3 | 15 | |
| 658 | Cortical surface area | NIMAG000009 | 1.45 | Neuroimaging | Neural / glial | 78 | 0 | 0 | 0 | |
| 659 | NCS1/NPY ratio | PRORT001576 | 1.45 | Protein ratios | Hepatocyte | 58 | 2 | 7 | 15 | |
| 660 | LCN2/PRTN3 ratio | PRORT001442 | 1.45 | Protein ratios | Myeloid | 25 | 3 | 10 | 13 | |
| 661 | LGALS9/SIGLEC1 ratio | PRORT001456 | 1.45 | Protein ratios | Myeloid | 15 | 3 | 13 | 17 | |
| 662 | CCL22/PDGFB ratio | PRORT000351 | 1.45 | Protein ratios | Hepatocyte | 7 | 3 | 15 | 43 | |
| 663 | CSF3R levels | PROLV000541 | 1.44 | Protein levels | Myeloid | 76 | 1 | 4 | 10 | |
| 664 | CRADD/FADD ratio | PRORT000745 | 1.44 | Protein ratios | Hematopoietic progenitor | 0 | 4 | 8 | 7 | |
| 665 | CDH17/GALNT3 ratio | PRORT000548 | 1.44 | Protein ratios | Neural / glial | 1 | 1 | 8 | 8 | |
| 666 | ADGRE5/NOTCH1 ratio | PRORT000032 | 1.44 | Protein ratios | Myeloid | 54 | 3 | 13 | 15 | |
| 667 | Knee derangements | MSKEL000016 | 1.44 | Musculoskeletal | Stromal / connective | 5 | 1 | 2 | 7 | |
| 668 | GRAP2/SNX9 ratio | PRORT001245 | 1.43 | Protein ratios | Hepatocyte | 6 | 4 | 7 | 27 | |
| 669 | ANGPT2 levels | PROLV000094 | 1.43 | Protein levels | Hepatocyte | 72 | 3 | 10 | 21 | |
| 670 | CAPG levels | PROLV000262 | 1.42 | Protein levels | Lymphocyte | 34 | 3 | 16 | 42 | |
| 671 | Anal and rectal disorder | GASTR000001 | 1.42 | Gastrointestinal | Gastrointestinal epithelium | 1 | 0 | 7 | 4 | |
| 672 | CD79B/FCRL2 ratio | PRORT000511 | 1.42 | Protein ratios | Stromal / connective | 17 | 2 | 7 | 12 | |
| 673 | Emphysema | RESPI000011 | 1.42 | Respiratory | Hepatocyte | 1 | 1 | 7 | 16 | |
| 674 | ADAMTS13 levels | PROLV000031 | 1.42 | Protein levels | Hepatocyte | 161 | 2 | 10 | 17 | |
| 675 | Retinal disorder | OPHTH000040 | 1.42 | Ophthalmic | Hepatocyte | 88 | 0 | 2 | 3 | |
| 676 | SERPING1 levels | PROLV001834 | 1.42 | Protein levels | Myeloid | 141 | 3 | 12 | 23 | |
| 677 | PRCP/SELE ratio | PRORT001709 | 1.42 | Protein ratios | Granulosa cell | 0 | 2 | 6 | 18 | |
| 678 | Fatty acids metabolites | METAB000052 | 1.42 | Metabolites | Hepatocyte | 20 | 2 | 4 | 18 | |
| 679 | TSPAN8 levels | PROLV002116 | 1.42 | Protein levels | Hepatocyte | 56 | 1 | 9 | 15 | |
| 680 | MOG levels | PROLV001332 | 1.41 | Protein levels | Pancreatic epithelium | 7 | 0 | 6 | 13 | |
| 681 | SERPINA3 levels | PROLV001817 | 1.41 | Protein levels | Myeloid | 2 | 3 | 8 | 14 | |
| 682 | Gut microbial abundance, Rikenellaceae | GASTR000034 | 1.41 | Gastrointestinal | Neural / glial | 0 | 6 | 10 | 28 | |
| 683 | Macular puckering of retina | OPHTH000037 | 1.41 | Ophthalmic | Stromal / connective | 17 | 3 | 8 | 11 | |
| 684 | MAX levels | PROLV001280 | 1.40 | Protein levels | Myeloid | 32 | 3 | 7 | 11 | |
| 685 | FABP1 levels | PROLV000751 | 1.40 | Protein levels | Neural / glial | 0 | 2 | 9 | 16 | |
| 686 | PDGFC levels | PROLV001524 | 1.40 | Protein levels | Hepatocyte | 95 | 2 | 8 | 16 | |
| 687 | Gut microbial abundance, Alistipes | GASTR000018 | 1.40 | Gastrointestinal | Neural / glial | 0 | 6 | 11 | 30 | |
| 688 | FCRLB levels | PROLV000788 | 1.40 | Protein levels | B / plasma cell | 86 | 3 | 8 | 21 | |
| 689 | Muscle fat infiltration | BCOMP000011 | 1.40 | Body composition | Myeloid | 40 | 2 | 8 | 20 | |
| 690 | Retinal vascular morphology | OPHTH000045 | 1.40 | Ophthalmic | Vascular | 253 | 2 | 5 | 7 | |
| 691 | EFNA1 levels | PROLV000681 | 1.40 | Protein levels | Vascular | 45 | 2 | 11 | 22 | |
| 692 | ECG QRS-T angle | CARDI000033 | 1.39 | Cardiac | Muscle / cardiac | 57 | 2 | 4 | 10 | |
| 693 | Corrective lens use | OPHTH000032 | 1.39 | Ophthalmic | Neural / glial | 66 | 8 | 14 | 25 | |
| 694 | Memory disorder | PSYCH000006 | 1.39 | Psychiatric | Neural / glial | 1 | 1 | 4 | 8 | |
| 695 | AXIN1/HEXIM1 ratio | PRORT000170 | 1.39 | Protein ratios | Stromal / connective | 1 | 3 | 10 | 23 | |
| 696 | IGFBP6 levels | PROLV001032 | 1.39 | Protein levels | Hepatocyte | 24 | 1 | 5 | 7 | |
| 697 | Benign neoplasm, Uterus | MALIG000008 | 1.38 | Malignancy | Lymphocyte | 38 | 0 | 2 | 26 | |
| 698 | ALDH1A1 levels | PROLV000079 | 1.38 | Protein levels | Hepatocyte | 16 | 2 | 9 | 22 | |
| 699 | LEPR/NTRK2 ratio | PRORT001448 | 1.38 | Protein ratios | Neural / glial | 24 | 4 | 10 | 21 | |
| 700 | Lipoprotein particles, VLDL | LIPID000046 | 1.38 | Lipids | Hepatocyte | 1,175 | 2 | 8 | 20 | |
| 701 | PKLR/UBAC1 ratio | PRORT001669 | 1.38 | Protein ratios | Muscle / cardiac | 11 | 1 | 7 | 8 | |
| 702 | CD70 levels | PROLV000353 | 1.37 | Protein levels | Muscle / cardiac | 6 | 3 | 11 | 20 | |
| 703 | RAPGEF2 levels | PROLV001705 | 1.37 | Protein levels | Stromal / connective | 2 | 2 | 17 | 40 | |
| 704 | Cholesteryl esters, HDL | LIPID000015 | 1.37 | Lipids | Hepatocyte | 2,085 | 3 | 9 | 17 | |
| 705 | CLEC1B/MGLL ratio | PRORT000643 | 1.37 | Protein ratios | Vascular | 24 | 6 | 14 | 30 | |
| 706 | AXIN1/MAVS ratio | PRORT000175 | 1.37 | Protein ratios | Neural / glial | 6 | 3 | 16 | 35 | |
| 707 | L1CAM levels | PROLV001171 | 1.37 | Protein levels | Vascular | 70 | 6 | 12 | 37 | |
| 708 | RGMB levels | PROLV001729 | 1.37 | Protein levels | Neural / glial | 21 | 1 | 6 | 7 | |
| 709 | RGMA levels | PROLV001728 | 1.36 | Protein levels | Muscle / cardiac | 126 | 1 | 7 | 11 | |
| 710 | Cholesterol, HDL | LIPID000003 | 1.36 | Lipids | Hepatocyte | 4,625 | 3 | 8 | 17 | |
| 711 | PSMG3 levels | PROLV001660 | 1.36 | Protein levels | Muscle / cardiac | 21 | 3 | 10 | 24 | |
| 712 | APOM levels | PROLV000128 | 1.36 | Protein levels | Hepatocyte | 122 | 2 | 8 | 20 | |
| 713 | Phospholipids, VLDL | LIPID000051 | 1.36 | Lipids | Hepatocyte | 1,563 | 2 | 8 | 19 | |
| 714 | Bone marrow fat fraction, femur | MSKEL000001 | 1.35 | Musculoskeletal | Adipose | 27 | 3 | 8 | 14 | |
| 715 | Biliary cirrhosis | HPBIL000005 | 1.35 | Hepatopancreatobiliary | Salivary epithelium | — | 0 | 12 | 10 | |
| 716 | ACAN levels | PROLV000010 | 1.35 | Protein levels | Stromal / connective | 76 | 3 | 7 | 17 | |
| 717 | NTRK2 levels | PROLV001447 | 1.35 | Protein levels | Myeloid | 73 | 3 | 11 | 21 | |
| 718 | Body fat percentage | BCOMP000004 | 1.35 | Body composition | Neural / glial | 409 | 3 | 9 | 19 | |
| 719 | PTP4A3 levels | PROLV001670 | 1.35 | Protein levels | Myeloid | 2 | 2 | 16 | 21 | |
| 720 | ANGPTL4 levels | PROLV000098 | 1.35 | Protein levels | Hepatocyte | 49 | 3 | 9 | 23 | |
| 721 | PEPD levels | PROLV001536 | 1.35 | Protein levels | Myeloid | 66 | 2 | 7 | 7 | |
| 722 | SCARF2 levels | PROLV001783 | 1.35 | Protein levels | Adipose | 49 | 2 | 6 | 11 | |
| 723 | CD58/MEGF10 ratio | PRORT000477 | 1.34 | Protein ratios | Muscle / cardiac | 15 | 5 | 19 | 37 | |
| 724 | EPO/TFRC ratio | PRORT001040 | 1.34 | Protein ratios | Lymphocyte | 0 | 4 | 7 | 15 | |
| 725 | Total lipids, VLDL | LIPID000077 | 1.34 | Lipids | Hepatocyte | 1,057 | 2 | 8 | 17 | |
| 726 | ANPEP/DPP4 ratio | PRORT000101 | 1.34 | Protein ratios | Hepatocyte | 25 | 3 | 11 | 18 | |
| 727 | CEACAM21 levels | PROLV000391 | 1.34 | Protein levels | Hepatocyte | 22 | 2 | 15 | 22 | |
| 728 | IFIT3 levels | PROLV001017 | 1.34 | Protein levels | Stromal / connective | 0 | 2 | 5 | 12 | |
| 729 | Grey matter volume | NIMAG000023 | 1.34 | Neuroimaging | Stromal / connective | 53 | 0 | 0 | 0 | |
| 730 | CDC27 levels | PROLV000367 | 1.34 | Protein levels | Lymphocyte | 4 | 3 | 9 | 24 | |
| 731 | DKK4 levels | PROLV000622 | 1.33 | Protein levels | Vascular | 53 | 2 | 10 | 18 | |
| 732 | APEX1/LSP1 ratio | PRORT000116 | 1.33 | Protein ratios | Myeloid | 14 | 4 | 9 | 14 | |
| 733 | Menstrual disorder | REPRO000021 | 1.33 | Reproductive | Vascular | 6 | 0 | 2 | 3 | |
| 734 | FCRL2/LY9 ratio | PRORT001130 | 1.33 | Protein ratios | B / plasma cell | 27 | 2 | 8 | 38 | |
| 735 | ESR1 levels | PROLV000735 | 1.33 | Protein levels | Adipose | 0 | 3 | 13 | 27 | |
| 736 | CCN3/PGF ratio | PRORT000374 | 1.32 | Protein ratios | Vascular | 2 | 4 | 6 | 28 | |
| 737 | DNAJA2/FIS1 ratio | PRORT000920 | 1.32 | Protein ratios | Granulosa cell | 0 | 4 | 13 | 24 | |
| 738 | Joint replacement | MSKEL000049 | 1.32 | Musculoskeletal | Hepatocyte | 7 | 1 | 5 | 6 | |
| 739 | SCARA3 levels | PROLV001779 | 1.32 | Protein levels | Epithelial | 0 | 1 | 16 | 30 | |
| 740 | KLK6/MOG ratio | PRORT001409 | 1.32 | Protein ratios | Myeloid | 8 | 4 | 12 | 15 | |
| 741 | DFFA/FOXO1 ratio | PRORT000887 | 1.31 | Protein ratios | Muscle / cardiac | 0 | 2 | 7 | 22 | |
| 742 | Cancer, Breast | MALIG000011 | 1.31 | Malignancy | Cutaneous epithelium | 47 | 1 | 8 | 13 | |
| 743 | TCTN3 levels | PROLV002005 | 1.31 | Protein levels | Hepatocyte | 89 | 3 | 10 | 20 | |
| 744 | CTSO/IGF2R ratio | PRORT000803 | 1.31 | Protein ratios | Hepatocyte | 20 | 4 | 13 | 26 | |
| 745 | LAMP1 levels | PROLV001180 | 1.31 | Protein levels | Myeloid | 47 | 3 | 9 | 19 | |
| 746 | CDHR2 levels | PROLV000379 | 1.31 | Protein levels | Hepatocyte | 103 | 2 | 13 | 22 | |
| 747 | Liver enzyme levels, AST | HPBIL000014 | 1.31 | Hepatopancreatobiliary | Hepatocyte | 1,947 | 3 | 13 | 18 | |
| 748 | OMD levels | PROLV001468 | 1.31 | Protein levels | Myeloid | 95 | 4 | 7 | 13 | |
| 749 | APP/NID2 ratio | PRORT000129 | 1.31 | Protein ratios | Stromal / connective | 0 | 2 | 6 | 11 | |
| 750 | SEZ6L levels | PROLV001841 | 1.31 | Protein levels | Myeloid | 76 | 2 | 8 | 7 | |
| 751 | ACVRL1/TNFRSF10B ratio | PRORT000016 | 1.31 | Protein ratios | Myeloid | 40 | 3 | 11 | 16 | |
| 752 | NRP1 levels | PROLV001434 | 1.30 | Protein levels | Hepatocyte | 128 | 2 | 10 | 21 | |
| 753 | Joint disorder | MSKEL000015 | 1.30 | Musculoskeletal | Stromal / connective | 2 | 3 | 10 | 14 | |
| 754 | CD244/CD84 ratio | PRORT000405 | 1.30 | Protein ratios | Myeloid | 16 | 1 | 8 | 8 | |
| 755 | PLAUR/TREM2 ratio | PRORT001680 | 1.30 | Protein ratios | Hepatocyte | 73 | 3 | 12 | 16 | |
| 756 | F13B levels | PROLV000744 | 1.29 | Protein levels | Myeloid | 36 | 3 | 14 | 18 | |
| 757 | IFIT2 levels | PROLV001016 | 1.29 | Protein levels | Myeloid | 17 | 5 | 9 | 20 | |
| 758 | ANG/F9 ratio | PRORT000089 | 1.29 | Protein ratios | Hepatocyte | 31 | 1 | 6 | 6 | |
| 759 | CXCL10/WARS ratio | PRORT000815 | 1.29 | Protein ratios | Hepatocyte | 4 | 2 | 9 | 17 | |
| 760 | Medication, heart failure | CARDI000044 | 1.29 | Cardiac | Hepatocyte | 0 | 3 | 6 | 20 | |
| 761 | TFPI2 levels | PROLV002016 | 1.29 | Protein levels | Myeloid | 105 | 2 | 7 | 15 | |
| 762 | GPR37 levels | PROLV000929 | 1.29 | Protein levels | Hepatocyte | 88 | 2 | 9 | 21 | |
| 763 | C1QTNF1/COL4A1 ratio | PRORT000263 | 1.29 | Protein ratios | Granulosa cell | 30 | 2 | 5 | 14 | |
| 764 | Bacterial intestinal infection | IMMUN000052 | 1.29 | Immunologic | Neural / glial | 0 | 1 | 2 | 9 | |
| 765 | CDH17 levels | PROLV000373 | 1.28 | Protein levels | Myeloid | 57 | 1 | 5 | 14 | |
| 766 | White matter microstructure | NIMAG000013 | 1.28 | Neuroimaging | Neural / glial | 96 | 0 | 0 | 3 | |
| 767 | ROBO1/SPON1 ratio | PRORT001744 | 1.28 | Protein ratios | Vascular | 3 | 3 | 7 | 12 | |
| 768 | Atherosclerosis | VASCU000006 | 1.28 | Vascular | Hepatocyte | 177 | 2 | 10 | 20 | |
| 769 | SMPD1/SMPDL3A ratio | PRORT001792 | 1.28 | Protein ratios | Hepatocyte | 4 | 2 | 12 | 14 | |
| 770 | SMOC2 levels | PROLV001900 | 1.28 | Protein levels | Stromal / connective | 4 | 0 | 1 | 2 | |
| 771 | ROBO1 levels | PROLV001749 | 1.28 | Protein levels | Myeloid | 129 | 2 | 7 | 15 | |
| 772 | UXS1 levels | PROLV002147 | 1.28 | Protein levels | Myeloid | 16 | 2 | 8 | 9 | |
| 773 | ASGR1/GGT5 ratio | PRORT000148 | 1.28 | Protein ratios | Hepatocyte | 60 | 1 | 9 | 18 | |
| 774 | ATXN2L levels | PROLV000165 | 1.28 | Protein levels | Stromal / connective | 0 | 1 | 6 | 16 | |
| 775 | SCGB1A1 levels | PROLV001786 | 1.28 | Protein levels | Respiratory epithelium | 54 | 0 | 2 | 7 | |
| 776 | LRP11/NECTIN2 ratio | PRORT001460 | 1.28 | Protein ratios | Vascular | 14 | 2 | 10 | 10 | |
| 777 | ITGB1 levels | PROLV001111 | 1.28 | Protein levels | Myeloid | 78 | 4 | 10 | 28 | |
| 778 | LBP levels | PROLV001188 | 1.27 | Protein levels | Hepatocyte | 18 | 2 | 7 | 22 | |
| 779 | ITGA5/SELE ratio | PRORT001372 | 1.26 | Protein ratios | Granulosa cell | 1 | 3 | 9 | 18 | |
| 780 | MPIG6B/PDGFB ratio | PRORT001557 | 1.26 | Protein ratios | Myeloid | 3 | 4 | 11 | 21 | |
| 781 | MMP3 levels | PROLV001325 | 1.26 | Protein levels | Myeloid | 51 | 1 | 6 | 8 | |
| 782 | GLB1/PCSK9 ratio | PRORT001217 | 1.26 | Protein ratios | Hepatocyte | 90 | 3 | 15 | 19 | |
| 783 | BCL2L2 levels | PROLV000189 | 1.26 | Protein levels | Vascular | 0 | 2 | 5 | 9 | |
| 784 | Brain general volume | NIMAG000015 | 1.26 | Neuroimaging | Neural / glial | 5 | 2 | 6 | 15 | |
| 785 | FUT8/VEGFC ratio | PRORT001193 | 1.25 | Protein ratios | Vascular | 3 | 5 | 21 | 43 | |
| 786 | EPO levels | PROLV000721 | 1.25 | Protein levels | Muscle / cardiac | 23 | 2 | 7 | 18 | |
| 787 | Triglycerides, total | LIPID000037 | 1.25 | Lipids | Hepatocyte | 2,195 | 3 | 7 | 16 | |
| 788 | CKAP2 levels | PROLV000438 | 1.25 | Protein levels | Neural / glial | 1 | 4 | 7 | 19 | |
| 789 | PLAU levels | PROLV001572 | 1.25 | Protein levels | Hepatocyte | 111 | 3 | 7 | 20 | |
| 790 | Free androgen index | ENDOC000007 | 1.25 | Endocrine | Hepatocyte | 616 | 1 | 6 | 20 | |
| 791 | FUS levels | PROLV000836 | 1.25 | Protein levels | Vascular | 2 | 5 | 11 | 21 | |
| 792 | DEFB4A or DEFB4B levels | PROLV000614 | 1.25 | Protein levels | Hepatocyte | 48 | 1 | 7 | 15 | |
| 793 | LTB4R levels | PROLV001241 | 1.25 | Protein levels | Myeloid | 8 | 3 | 12 | 18 | |
| 794 | GCG levels | PROLV000866 | 1.25 | Protein levels | Hepatocyte | 66 | 1 | 7 | 13 | |
| 795 | CHL1 levels | PROLV000430 | 1.25 | Protein levels | Hepatocyte | 10 | 3 | 6 | 15 | |
| 796 | GZMA/TNFRSF8 ratio | PRORT001262 | 1.24 | Protein ratios | Lymphocyte | 48 | 4 | 14 | 44 | |
| 797 | PDLIM7/PLA2G4A ratio | PRORT001654 | 1.24 | Protein ratios | Platelet | 8 | 4 | 5 | 18 | |
| 798 | Cancer, Colorectal | MALIG000013 | 1.24 | Malignancy | Epithelial | 27 | 0 | 3 | 2 | |
| 799 | ALCAM/ENPP2 ratio | PRORT000070 | 1.24 | Protein ratios | Hepatocyte | 51 | 3 | 12 | 18 | |
| 800 | RBKS levels | PROLV001709 | 1.24 | Protein levels | Hepatocyte | 23 | 1 | 7 | 17 | |
| 801 | Family history, coronary artery disease | VASCU000021 | 1.24 | Vascular | Vascular | 26 | 0 | 2 | 7 | |
| 802 | CD244/GP1BA ratio | PRORT000409 | 1.24 | Protein ratios | Hematopoietic progenitor | 5 | 2 | 12 | 34 | |
| 803 | PPP3R1 levels | PROLV001620 | 1.23 | Protein levels | Myeloid | 20 | 2 | 10 | 18 | |
| 804 | PDGFRA levels | PROLV001525 | 1.23 | Protein levels | Hepatocyte | 55 | 2 | 4 | 14 | |
| 805 | Tyrosine | METAB000031 | 1.23 | Metabolites | Hepatocyte | 258 | 1 | 5 | 10 | |
| 806 | APOE levels | PROLV000124 | 1.23 | Protein levels | Neural / glial | 46 | 4 | 13 | 21 | |
| 807 | FCRL3 levels | PROLV000785 | 1.23 | Protein levels | Lymphocyte | 48 | 2 | 9 | 18 | |
| 808 | ENO2/PRSS27 ratio | PRORT001028 | 1.23 | Protein ratios | Myeloid | 0 | 2 | 7 | 30 | |
| 809 | MAVS/PPP1R9B ratio | PRORT001498 | 1.23 | Protein ratios | Adipose | 0 | 3 | 12 | 33 | |
| 810 | CLIP2/NT5C3A ratio | PRORT000667 | 1.23 | Protein ratios | Muscle / cardiac | 0 | 4 | 5 | 13 | |
| 811 | PON2/PON3 ratio | PRORT001698 | 1.22 | Protein ratios | Hepatocyte | 8 | 2 | 6 | 20 | |
| 812 | Frailty, multimorbidity | METBL000012 | 1.22 | Metabolic | Vascular | 188 | 3 | 10 | 10 | |
| 813 | Eyelid disorder | OPHTH000019 | 1.22 | Ophthalmic | Adipose | 14 | 1 | 1 | 3 | |
| 814 | CNTNAP2/DPP10 ratio | PRORT000689 | 1.22 | Protein ratios | Vascular | 0 | 1 | 4 | 9 | |
| 815 | Sleep apnoea | RESPI000035 | 1.22 | Respiratory | Neural / glial | 73 | 1 | 2 | 10 | |
| 816 | PSAP levels | PROLV001653 | 1.21 | Protein levels | Myeloid | 52 | 2 | 7 | 16 | |
| 817 | QPCT levels | PROLV001693 | 1.21 | Protein levels | Lymphocyte | 72 | 3 | 9 | 24 | |
| 818 | CLIP2/DNAJA2 ratio | PRORT000665 | 1.21 | Protein ratios | Muscle / cardiac | 0 | 3 | 10 | 18 | |
| 819 | TDRKH levels | PROLV002008 | 1.21 | Protein levels | Vascular | 14 | 4 | 6 | 16 | |
| 820 | BCAM/EPO ratio | PRORT000208 | 1.21 | Protein ratios | Vascular | 30 | 2 | 8 | 10 | |
| 821 | Cortical volume | NIMAG000022 | 1.21 | Neuroimaging | Stromal / connective | 22 | 0 | 0 | 0 | |
| 822 | PTPN1/TDRKH ratio | PRORT001717 | 1.21 | Protein ratios | Granulosa cell | 1 | 2 | 5 | 7 | |
| 823 | CD164/PARK7 ratio | PRORT000389 | 1.21 | Protein ratios | Neural / glial | 0 | 6 | 10 | 25 | |
| 824 | Polycystic ovary syndrome | REPRO000024 | 1.21 | Reproductive | Granulosa cell | 29 | 2 | 4 | 19 | |
| 825 | SLC27A4/TDRKH ratio | PRORT001790 | 1.21 | Protein ratios | Stromal / connective | 0 | 1 | 4 | 11 | |
| 826 | GRN levels | PROLV000933 | 1.20 | Protein levels | Myeloid | 36 | 1 | 4 | 9 | |
| 827 | REG4/SPINK4 ratio | PRORT001733 | 1.20 | Protein ratios | Myeloid | 0 | 0 | 2 | 10 | |
| 828 | LYN/TACC3 ratio | PRORT001473 | 1.20 | Protein ratios | B / plasma cell | 0 | 6 | 9 | 16 | |
| 829 | Pre-eclampsia | VASCU000047 | 1.20 | Vascular | Myeloid | 7 | 2 | 3 | 7 | |
| 830 | Insomnia | PSYCH000038 | 1.20 | Psychiatric | Neural / glial | 63 | 2 | 6 | 14 | |
| 831 | NCS1 levels | PROLV001385 | 1.19 | Protein levels | Myeloid | 105 | 3 | 8 | 14 | |
| 832 | CCDC80 levels | PROLV000276 | 1.19 | Protein levels | Myeloid | 30 | 2 | 6 | 14 | |
| 833 | EDA2R levels | PROLV000673 | 1.19 | Protein levels | B / plasma cell | 20 | 4 | 12 | 26 | |
| 834 | CLMP levels | PROLV000461 | 1.19 | Protein levels | Adipose | 9 | 2 | 6 | 5 | |
| 835 | FGF19/SCG2 ratio | PRORT001139 | 1.19 | Protein ratios | Hepatocyte | 29 | 2 | 8 | 13 | |
| 836 | CRADD/EREG ratio | PRORT000744 | 1.19 | Protein ratios | Myeloid | 1 | 3 | 9 | 17 | |
| 837 | Sputum production | RESPI000033 | 1.19 | Respiratory | Myeloid | 0 | 4 | 9 | 14 | |
| 838 | Testosterone | ENDOC000010 | 1.19 | Endocrine | Hepatocyte | 939 | 2 | 6 | 23 | |
| 839 | MESD/SNX9 ratio | PRORT001517 | 1.18 | Protein ratios | Stromal / connective | 1 | 5 | 10 | 28 | |
| 840 | ACVRL1/TNFRSF9 ratio | PRORT000018 | 1.18 | Protein ratios | Myeloid | 12 | 2 | 11 | 19 | |
| 841 | Urinary tract infection | IMMUN000074 | 1.18 | Immunologic | Neural / glial | 1 | 1 | 3 | 7 | |
| 842 | Infertility | REPRO000010 | 1.18 | Reproductive | Vascular | 0 | 0 | 2 | 9 | |
| 843 | ALPI levels | PROLV000082 | 1.18 | Protein levels | Stromal / connective | 4 | 0 | 4 | 21 | |
| 844 | Male genital disorder | REPRO000013 | 1.17 | Reproductive | Granulosa cell | 7 | 0 | 7 | 9 | |
| 845 | C-reactive protein | HPBIL000026 | 1.17 | Hepatopancreatobiliary | Hepatocyte | 1,267 | 3 | 10 | 20 | |
| 846 | SH2B3/SUGT1 ratio | PRORT001783 | 1.17 | Protein ratios | Muscle / cardiac | 24 | 3 | 9 | 23 | |
| 847 | BCAM levels | PROLV000181 | 1.17 | Protein levels | Hepatocyte | 79 | 2 | 14 | 15 | |
| 848 | ADGRG2 levels | PROLV000047 | 1.17 | Protein levels | Myeloid | 24 | 2 | 8 | 15 | |
| 849 | AZU1/MPO ratio | PRORT000185 | 1.17 | Protein ratios | Myeloid | 8 | 1 | 4 | 8 | |
| 850 | NOTCH3/PTPRS ratio | PRORT001593 | 1.16 | Protein ratios | Vascular | 59 | 5 | 14 | 26 | |
| 851 | SPARCL1 levels | PROLV001924 | 1.16 | Protein levels | Hepatocyte | 112 | 2 | 9 | 18 | |
| 852 | Keloid and scarring | DERMA000041 | 1.16 | Dermatologic | Muscle / cardiac | 17 | 2 | 3 | 19 | |
| 853 | CST6 levels | PROLV000551 | 1.16 | Protein levels | Cutaneous epithelium | 33 | 1 | 10 | 10 | |
| 854 | Cholesterol, VLDL free | LIPID000008 | 1.16 | Lipids | Hepatocyte | 1,347 | 2 | 8 | 17 | |
| 855 | MSTN levels | PROLV001345 | 1.16 | Protein levels | Muscle / cardiac | 17 | 2 | 9 | 17 | |
| 856 | PON3 levels | PROLV001602 | 1.16 | Protein levels | Hepatocyte | 81 | 4 | 9 | 26 | |
| 857 | SPRR3 levels | PROLV001939 | 1.16 | Protein levels | Gastrointestinal epithelium | 3 | 0 | 3 | 5 | |
| 858 | IL1RL1 levels | PROLV001063 | 1.16 | Protein levels | Stromal / connective | 20 | 1 | 3 | 11 | |
| 859 | BCAN levels | PROLV000182 | 1.16 | Protein levels | Myeloid | 115 | 2 | 7 | 10 | |
| 860 | NT5C1A levels | PROLV001439 | 1.16 | Protein levels | Muscle / cardiac | 8 | 4 | 16 | 25 | |
| 861 | MAP2K6 levels | PROLV001267 | 1.15 | Protein levels | Muscle / cardiac | 13 | 5 | 13 | 22 | |
| 862 | PLA2G15/PRCP ratio | PRORT001670 | 1.15 | Protein ratios | Myeloid | 44 | 3 | 11 | 21 | |
| 863 | Otosclerosis | AUDIO000018 | 1.14 | Auditory | Granulosa cell | 16 | 5 | 10 | 16 | |
| 864 | Leg fat percentage | BCOMP000015 | 1.14 | Body composition | Neural / glial | 295 | 4 | 7 | 17 | |
| 865 | Chondrocalcinosis | MSKEL000014 | 1.14 | Musculoskeletal | Vascular | 0 | 1 | 6 | 12 | |
| 866 | DFFA levels | PROLV000615 | 1.14 | Protein levels | Stromal / connective | 1 | 3 | 10 | 13 | |
| 867 | Operation, gastrointestinal | GASTR000039 | 1.14 | Gastrointestinal | Hepatocyte | 208 | 1 | 2 | 11 | |
| 868 | BACH1/NFATC1 ratio | PRORT000196 | 1.14 | Protein ratios | Hepatocyte | 6 | 1 | 8 | 11 | |
| 869 | ACOT13 levels | PROLV000013 | 1.14 | Protein levels | Stromal / connective | 16 | 3 | 5 | 13 | |
| 870 | Cancer, Brain | MALIG000010 | 1.14 | Malignancy | Muscle / cardiac | 0 | 2 | 4 | 13 | |
| 871 | FIS1/HSPA1A ratio | PRORT001149 | 1.14 | Protein ratios | Hepatocyte | 34 | 3 | 9 | 20 | |
| 872 | SESTD1 levels | PROLV001838 | 1.14 | Protein levels | Muscle / cardiac | 12 | 4 | 8 | 23 | |
| 873 | Cholesterol, VLDL | LIPID000009 | 1.14 | Lipids | Hepatocyte | 1,391 | 2 | 9 | 14 | |
| 874 | NFATC1/TJAP1 ratio | PRORT001587 | 1.14 | Protein ratios | Muscle / cardiac | 0 | 1 | 6 | 8 | |
| 875 | JAM2/TGFBR2 ratio | PRORT001397 | 1.13 | Protein ratios | Adipose | 13 | 0 | 4 | 8 | |
| 876 | DNAJA2/PLXNA4 ratio | PRORT000923 | 1.13 | Protein ratios | Lymphocyte | 20 | 6 | 17 | 40 | |
| 877 | GOT1 levels | PROLV000912 | 1.13 | Protein levels | Myeloid | 21 | 3 | 12 | 13 | |
| 878 | Brain ventricle volume | NIMAG000016 | 1.13 | Neuroimaging | Stromal / connective | 27 | 1 | 2 | 13 | |
| 879 | Gout | METBL000043 | 1.13 | Metabolic | Hepatocyte | 506 | 1 | 10 | 10 | |
| 880 | KDR/VWF ratio | PRORT001402 | 1.13 | Protein ratios | Vascular | 8 | 2 | 7 | 14 | |
| 881 | MAVS/RNF41 ratio | PRORT001499 | 1.13 | Protein ratios | Muscle / cardiac | 19 | 5 | 9 | 16 | |
| 882 | RABGAP1L levels | PROLV001702 | 1.13 | Protein levels | Muscle / cardiac | 7 | 3 | 10 | 23 | |
| 883 | GPHA2 levels | PROLV000922 | 1.13 | Protein levels | Stromal / connective | 9 | 0 | 2 | 3 | |
| 884 | Cholesterol, HDL free | LIPID000001 | 1.12 | Lipids | Hepatocyte | 1,923 | 3 | 8 | 19 | |
| 885 | TAFA5 levels | PROLV001990 | 1.12 | Protein levels | Hepatocyte | 9 | 1 | 4 | 10 | |
| 886 | IRAK1/NFATC1 ratio | PRORT001368 | 1.12 | Protein ratios | Hepatocyte | 1 | 3 | 8 | 22 | |
| 887 | Surgical history | MISCL000031 | 1.12 | Miscellaneous | Hematopoietic progenitor | 22 | 1 | 1 | 6 | |
| 888 | PNLIPRP2 levels | PROLV001593 | 1.12 | Protein levels | Granulosa cell | 13 | 1 | 5 | 13 | |
| 889 | Fatty liver disease, nonalcoholic | HPBIL000031 | 1.12 | Hepatopancreatobiliary | Vascular | 19 | 1 | 7 | 16 | |
| 890 | CC2D1A/WWP2 ratio | PRORT000331 | 1.12 | Protein ratios | Stromal / connective | 0 | 0 | 4 | 5 | |
| 891 | CLEC6A levels | PROLV000456 | 1.12 | Protein levels | Myeloid | 53 | 3 | 9 | 17 | |
| 892 | EPCAM/GPA33 ratio | PRORT001035 | 1.12 | Protein ratios | B / plasma cell | 22 | 0 | 5 | 4 | |
| 893 | Cholesteryl esters, VLDL | LIPID000018 | 1.12 | Lipids | Hepatocyte | 1,427 | 2 | 8 | 17 | |
| 894 | FOLH1 levels | PROLV000821 | 1.12 | Protein levels | Hepatocyte | 7 | 0 | 3 | 10 | |
| 895 | ASAH2 levels | PROLV000150 | 1.11 | Protein levels | Myeloid | 115 | 3 | 7 | 17 | |
| 896 | CDHR5 levels | PROLV000380 | 1.11 | Protein levels | Hepatocyte | 114 | 1 | 5 | 9 | |
| 897 | IGFBP6/MFAP5 ratio | PRORT001336 | 1.11 | Protein ratios | Vascular | 0 | 2 | 11 | 19 | |
| 898 | SPP1 levels | PROLV001938 | 1.11 | Protein levels | Vascular | 68 | 4 | 9 | 23 | |
| 899 | SSH3 levels | PROLV001949 | 1.11 | Protein levels | Stromal / connective | — | 1 | 10 | 6 | |
| 900 | COL1A1 levels | PROLV000485 | 1.11 | Protein levels | B / plasma cell | 22 | 0 | 1 | 0 | |
| 901 | VEGFD levels | PROLV002160 | 1.11 | Protein levels | Hepatocyte | 25 | 2 | 9 | 23 | |
| 902 | SPINK5 levels | PROLV001930 | 1.11 | Protein levels | Renal epithelium | 10 | 1 | 14 | 20 | |
| 903 | AXL levels | PROLV000167 | 1.11 | Protein levels | Myeloid | 83 | 4 | 14 | 44 | |
| 904 | Consultant specialty, cardiology | CARDI000037 | 1.11 | Cardiac | Vascular | 51 | 4 | 13 | 19 | |
| 905 | ADAM9 levels | PROLV000030 | 1.11 | Protein levels | Myeloid | 119 | 3 | 12 | 18 | |
| 906 | Fibromuscular dysplasia | VASCU000024 | 1.11 | Vascular | Stromal / connective | 1 | 3 | 6 | 11 | |
| 907 | SCGN levels | PROLV001789 | 1.11 | Protein levels | Gastrointestinal epithelium | 12 | 0 | 6 | 12 | |
| 908 | C8B levels | PROLV000237 | 1.11 | Protein levels | Hepatocyte | 31 | 3 | 16 | 31 | |
| 909 | VWA1 levels | PROLV002179 | 1.11 | Protein levels | Hepatocyte | 83 | 2 | 10 | 14 | |
| 910 | ATXN10/SLC27A4 ratio | PRORT000163 | 1.11 | Protein ratios | Granulosa cell | 0 | 2 | 7 | 13 | |
| 911 | Tendinitis | MSKEL000070 | 1.11 | Musculoskeletal | Neural / glial | 0 | 1 | 3 | 9 | |
| 912 | Benign neoplasm, Skin | MALIG000007 | 1.11 | Malignancy | Melanocyte | 10 | 0 | 5 | 10 | |
| 913 | Phospholipids, HDL | LIPID000048 | 1.10 | Lipids | Hepatocyte | 2,061 | 3 | 9 | 16 | |
| 914 | SLITRK2 levels | PROLV001889 | 1.10 | Protein levels | Lymphocyte | 15 | 3 | 11 | 28 | |
| 915 | PPY levels | PROLV001622 | 1.10 | Protein levels | Vascular | 12 | 0 | 2 | 9 | |
| 916 | PTPN6/SNAP23 ratio | PRORT001719 | 1.10 | Protein ratios | Myeloid | 0 | 2 | 8 | 10 | |
| 917 | Lipoprotein particles, HDL | LIPID000043 | 1.10 | Lipids | Hepatocyte | 1,830 | 3 | 8 | 19 | |
| 918 | HEXIM1/NUB1 ratio | PRORT001279 | 1.10 | Protein ratios | Muscle / cardiac | 0 | 2 | 7 | 11 | |
| 919 | Total lipids, HDL | LIPID000074 | 1.10 | Lipids | Hepatocyte | 1,723 | 3 | 8 | 19 | |
| 920 | MTIF3 levels | PROLV001348 | 1.10 | Protein levels | Myeloid | 3 | 2 | 7 | 13 | |
| 921 | Urinary retention | NEPHR000015 | 1.10 | Nephrourologic | Lymphocyte | 0 | 0 | 1 | 5 | |
| 922 | Cancer, Testis | MALIG000031 | 1.09 | Malignancy | B / plasma cell | 0 | 0 | 1 | 7 | |
| 923 | CD99L2 levels | PROLV000364 | 1.09 | Protein levels | Hepatocyte | 88 | 1 | 7 | 18 | |
| 924 | NPY/SMOC1 ratio | PRORT001596 | 1.09 | Protein ratios | Hepatocyte | 49 | 2 | 8 | 14 | |
| 925 | CLEC14A/PIK3IP1 ratio | PRORT000627 | 1.09 | Protein ratios | Vascular | 6 | 2 | 9 | 14 | |
| 926 | CRKL/FIS1 ratio | PRORT000763 | 1.09 | Protein ratios | Hepatocyte | 1 | 1 | 12 | 15 | |
| 927 | CD300LG/CD93 ratio | PRORT000433 | 1.09 | Protein ratios | Vascular | 3 | 2 | 5 | 16 | |
| 928 | Family medical history, none | MISCL000010 | 1.09 | Miscellaneous | Vascular | 6 | 0 | 0 | 3 | |
| 929 | IGBP1 levels | PROLV001023 | 1.09 | Protein levels | Lymphocyte | 1 | 3 | 12 | 33 | |
| 930 | Ocular motility and refraction disorder | OPHTH000024 | 1.09 | Ophthalmic | Adipose | 7 | 3 | 5 | 12 | |
| 931 | DPP6/SEZ6L2 ratio | PRORT000948 | 1.09 | Protein ratios | Myeloid | 37 | 4 | 14 | 16 | |
| 932 | DSG3/DSG4 ratio | PRORT000952 | 1.08 | Protein ratios | Cutaneous epithelium | 11 | 1 | 6 | 11 | |
| 933 | NSFL1C/PSMG3 ratio | PRORT001599 | 1.08 | Protein ratios | Neural / glial | 19 | 4 | 7 | 20 | |
| 934 | NMI levels | PROLV001410 | 1.08 | Protein levels | Myeloid | 6 | 4 | 10 | 13 | |
| 935 | ADH4/KRT18 ratio | PRORT000040 | 1.08 | Protein ratios | Hepatocyte | 12 | 1 | 11 | 17 | |
| 936 | P4HB/PPP1R12A ratio | PRORT001618 | 1.08 | Protein ratios | Muscle / cardiac | 13 | 5 | 11 | 24 | |
| 937 | CRELD2/TXNDC5 ratio | PRORT000758 | 1.08 | Protein ratios | Myeloid | 2 | 3 | 9 | 11 | |
| 938 | CCER2 levels | PROLV000277 | 1.08 | Protein levels | Muscle / cardiac | 19 | 2 | 6 | 8 | |
| 939 | KRT5 levels | PROLV001167 | 1.08 | Protein levels | Cutaneous epithelium | 11 | 0 | 11 | 17 | |
| 940 | ALDH1A1/CA2 ratio | PRORT000077 | 1.08 | Protein ratios | Hepatocyte | 9 | 1 | 4 | 17 | |
| 941 | SMAD5 levels | PROLV001897 | 1.08 | Protein levels | Myeloid | 95 | 2 | 6 | 11 | |
| 942 | Anaemia of chronic kidney disease | HEMAT000003 | 1.08 | Hematologic | Hepatocyte | 4 | 3 | 7 | 14 | |
| 943 | A4GALT levels | PROLV000002 | 1.07 | Protein levels | Vascular | 7 | 0 | 2 | 1 | |
| 944 | FSTL3/LTBR ratio | PRORT001181 | 1.07 | Protein ratios | Vascular | 1 | 2 | 8 | 11 | |
| 945 | MEGF9/MET ratio | PRORT001513 | 1.07 | Protein ratios | Hepatocyte | 46 | 1 | 5 | 7 | |
| 946 | IFNGR1/THBD ratio | PRORT001332 | 1.07 | Protein ratios | Vascular | 22 | 3 | 9 | 14 | |
| 947 | Insulin levels | METBL000040 | 1.07 | Metabolic | Hepatocyte | 83 | 1 | 4 | 8 | |
| 948 | CDKN1A/TBL1X ratio | PRORT000573 | 1.07 | Protein ratios | Hepatocyte | 13 | 3 | 13 | 13 | |
| 949 | Dental caries | DENTA000004 | 1.07 | Dental | Stromal / connective | 2 | 1 | 4 | 7 | |
| 950 | Triglycerides, VLDL | LIPID000036 | 1.07 | Lipids | Hepatocyte | 1,580 | 3 | 8 | 16 | |
| 951 | SERPINB6 levels | PROLV001825 | 1.07 | Protein levels | Muscle / cardiac | 5 | 5 | 10 | 23 | |
| 952 | ALDH1A1/RBKS ratio | PRORT000080 | 1.07 | Protein ratios | Hematopoietic progenitor | 1 | 1 | 2 | 9 | |
| 953 | SERPINA6 levels | PROLV001820 | 1.07 | Protein levels | Hepatocyte | 34 | 2 | 10 | 13 | |
| 954 | PLA2G2A levels | PROLV001568 | 1.07 | Protein levels | Myeloid | 20 | 3 | 9 | 17 | |
| 955 | Microscopic colitis | IMMUN000033 | 1.07 | Immunologic | Muscle / cardiac | 7 | 1 | 4 | 12 | |
| 956 | FST levels | PROLV000829 | 1.07 | Protein levels | Granulosa cell | 34 | 2 | 6 | 15 | |
| 957 | CTHRC1 levels | PROLV000556 | 1.06 | Protein levels | Myeloid | 27 | 4 | 11 | 12 | |
| 958 | PPCDC/RWDD1 ratio | PRORT001699 | 1.06 | Protein ratios | Myeloid | 9 | 4 | 8 | 20 | |
| 959 | HPGDS levels | PROLV000985 | 1.06 | Protein levels | Myeloid | 40 | 4 | 11 | 22 | |
| 960 | ACVRL1/SCARB2 ratio | PRORT000015 | 1.06 | Protein ratios | Myeloid | 46 | 2 | 9 | 18 | |
| 961 | RELT levels | PROLV001722 | 1.06 | Protein levels | Vascular | 6 | 0 | 5 | 8 | |
| 962 | LAG3/VCAM1 ratio | PRORT001418 | 1.06 | Protein ratios | Hepatocyte | 24 | 4 | 13 | 36 | |
| 963 | SEZ6L2 levels | PROLV001842 | 1.06 | Protein levels | Myeloid | 148 | 2 | 6 | 12 | |
| 964 | Creativity | PSYCH000003 | 1.06 | Psychiatric | Neural / glial | 10 | 4 | 13 | 23 | |
| 965 | F10 levels | PROLV000740 | 1.06 | Protein levels | Hepatocyte | 80 | 3 | 10 | 14 | |
| 966 | APOB/APOA1 ratio | PRORT000117 | 1.06 | Protein ratios | Hepatocyte | 343 | 1 | 9 | 14 | |
| 967 | Ventricular wall thickness | CARDI000016 | 1.06 | Cardiac | Muscle / cardiac | 47 | 2 | 3 | 11 | |
| 968 | ITGB1/TFPI ratio | PRORT001381 | 1.06 | Protein ratios | Hepatocyte | 52 | 1 | 14 | 13 | |
| 969 | SMPD1 levels | PROLV001901 | 1.06 | Protein levels | Hepatocyte | 179 | 1 | 7 | 16 | |
| 970 | FABP2/RBP2 ratio | PRORT001099 | 1.06 | Protein ratios | Neural / glial | 2 | 4 | 14 | 20 | |
| 971 | MEPE levels | PROLV001299 | 1.06 | Protein levels | Muscle / cardiac | 39 | 2 | 7 | 17 | |
| 972 | F7 levels | PROLV000748 | 1.06 | Protein levels | Hepatocyte | 89 | 1 | 8 | 15 | |
| 973 | Heart rate variability | CARDI000022 | 1.06 | Cardiac | Muscle / cardiac | 10 | 2 | 4 | 15 | |
| 974 | Functional gastrointestinal disorder | GASTR000003 | 1.06 | Gastrointestinal | Neural / glial | 0 | 1 | 6 | 18 | |
| 975 | Arrhythmia | CARDI000018 | 1.06 | Cardiac | Muscle / cardiac | 192 | 2 | 4 | 9 | |
| 976 | FTCD levels | PROLV000832 | 1.05 | Protein levels | Hepatocyte | 62 | 1 | 8 | 22 | |
| 977 | Fatty acids, polyunsaturated | LIPID000026 | 1.05 | Lipids | Hepatocyte | 953 | 2 | 7 | 12 | |
| 978 | IL1R2 levels | PROLV001061 | 1.05 | Protein levels | Hepatocyte | 116 | 3 | 9 | 15 | |
| 979 | CD74/LILRB4 ratio | PRORT000505 | 1.05 | Protein ratios | Vascular | 42 | 4 | 9 | 21 | |
| 980 | Kidney cyst | NEPHR000004 | 1.05 | Nephrourologic | Stromal / connective | 12 | 1 | 6 | 13 | |
| 981 | CCN3 levels | PROLV000303 | 1.05 | Protein levels | Vascular | 8 | 1 | 4 | 10 | |
| 982 | CCN5/IGFBP6 ratio | PRORT000375 | 1.05 | Protein ratios | Stromal / connective | 6 | 1 | 3 | 18 | |
| 983 | Heart rate | CARDI000021 | 1.05 | Cardiac | Muscle / cardiac | 1,425 | 2 | 8 | 13 | |
| 984 | ESAM levels | PROLV000733 | 1.05 | Protein levels | Muscle / cardiac | 25 | 3 | 8 | 11 | |
| 985 | RP2 levels | PROLV001752 | 1.05 | Protein levels | Vascular | 29 | 2 | 8 | 11 | |
| 986 | DOK2/PDLIM7 ratio | PRORT000940 | 1.04 | Protein ratios | Muscle / cardiac | 6 | 4 | 14 | 19 | |
| 987 | Fatty acids, undecenoic acid | LIPID000030 | 1.04 | Lipids | Stromal / connective | 0 | 3 | 8 | 17 | |
| 988 | ADGRE2/CD58 ratio | PRORT000028 | 1.04 | Protein ratios | Myeloid | 43 | 3 | 11 | 17 | |
| 989 | IL17D levels | PROLV001052 | 1.04 | Protein levels | Hepatocyte | 18 | 4 | 8 | 25 | |
| 990 | Osteochondrodysplasia | MSKEL000054 | 1.04 | Musculoskeletal | B / plasma cell | 0 | 2 | 8 | 18 | |
| 991 | PGF levels | PROLV001544 | 1.04 | Protein levels | Vascular | 24 | 1 | 4 | 14 | |
| 992 | AHNAK2 levels | PROLV000063 | 1.04 | Protein levels | Adipose | 19 | 0 | 2 | 13 | |
| 993 | CST6/NECTIN4 ratio | PRORT000792 | 1.04 | Protein ratios | Epithelial | 3 | 1 | 5 | 13 | |
| 994 | CPXM1/MDK ratio | PRORT000735 | 1.03 | Protein ratios | Hematopoietic progenitor | 20 | 3 | 6 | 22 | |
| 995 | HS6ST2 levels | PROLV000991 | 1.03 | Protein levels | Muscle / cardiac | 28 | 3 | 7 | 15 | |
| 996 | IRAK1 levels | PROLV001097 | 1.03 | Protein levels | Vascular | 10 | 3 | 10 | 15 | |
| 997 | FBP1/GSTA1 ratio | PRORT001118 | 1.03 | Protein ratios | Myeloid | 51 | 2 | 9 | 17 | |
| 998 | C1QTNF1/COL18A1 ratio | PRORT000262 | 1.03 | Protein ratios | B / plasma cell | 6 | 3 | 8 | 18 | |
| 999 | DARS1/EIF4B ratio | PRORT000858 | 1.03 | Protein ratios | Hepatocyte | 0 | 3 | 8 | 30 | |
| 1000 | NT5C3A levels | PROLV001440 | 1.03 | Protein levels | Stromal / connective | 13 | 6 | 11 | 20 |